logo

業績Result

2023年業績

原著論文(英文)

  1. Hasegawa T, Yoshida M, Watanabe S, Kondo T, Asada H, Nakagawa A, Tomii K, Kameda M, Otsuka M, Kuronuma K, Chiba H, Katayanagi S, Miyazaki Y, Mori A. Development of a new HISCL automated CXCL9 immunoassay. Sci Rep. 2023 04;13(1):5342.
  2. Peljto AL, Blumhagen RZ, Walts AD, Cardwell J, Powers J, Corte TJ, Dickinson JL, Glaspole I, Moodley YP, Vasakova MK, Bendstrup E, Davidsen JR, Borie R, Crestani B, Dieude P, Bonella F, Costabel U, Gudmundsson G, Donnelly SC, Egan J, Henry MT, Keane MP, Kennedy MP, McCarthy C, McElroy AN, Olaniyi JA, O'Reilly KMA, Richeldi L, Leone PM, Poletti V, Puppo F, Tomassetti S, Luzzi V, Kokturk N, Mogulkoc N, Fiddler CA, Hirani N, Jenkins RG, Maher TM, Molyneaux PL, Parfrey H, Braybrooke R, Blackwell TS, Jackson PD, Nathan SD, Porteous MK, Brown KK, Christie JD, Collard HR, Eickelberg O, Foster EE, Gibson KF, Glassberg M, Kass DJ, Kropski JA, Lederer D, Linderholm AL, Loyd J, Mathai SK, Montesi SB, Noth I, Oldham JM, Palmisciano AJ, Reichner CA, Rojas M, Roman J, Schluger N, Shea BS, Swigris JJ, Wolters PJ, Zhang Y, Prele CMA, Enghelmayer JI, Otaola M, Ryerson CJ, Salinas M, Sterclova M, Gebremariam TH, Myllärniemi M, Carbone RG, Furusawa H, Hirose M, Inoue Y, Miyazaki Y, Ohta K, Ohta S, Okamoto T, Kim DS, Pardo A, Selman M, Aranda AU, Park MS, Park JS, Song JW, Molina-Molina M, Planas-Cerezales L, Westergren-Thorsson G, Smith AV, Manichaikul AW, Kim JS, Rich SS, Oelsner EC, Barr RG, Rotter JI, Dupuis J, O'Connor G, Vasan RS, Cho MH, Silverman EK, Schwarz MI, Steele MP, Lee JS, Yang IV, Fingerlin TE, Schwartz DA. Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants. Am J Respir Crit Care Med. 2023 05;207(9):1194-1202.
  3. Tateishi T, Shimada S, Yamana T, Iijima Y, Sakakibara R, Mitsumura T, Shibata S, Honda T, Shirai T, Okamoto T, Tamaoka M, Sasai T, Miyazaki Y. COVID-19 Pneumonia Followed by Anti-signal Recognition Particle Antibody-positive Fibrosing Interstitial Lung Disease. Intern Med. 2023 05;62(9):1323-1328.
  4. Edahiro R, Shirai Y, Takeshima Y, Sakakibara S, Yamaguchi Y, Murakami T, Morita T, Kato Y, Liu YC, Motooka D, Naito Y, Takuwa A, Sugihara F, Tanaka K, Wing JB, Sonehara K, Tomofuji Y; Japan COVID-19 Task Force; Namkoong H, Tanaka H, Lee H, Fukunaga K, Hirata H, Takeda Y, Okuzaki D, Kumanogoh A, Okada Y. Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity. Nat Genet. 2023 05;55(5):753-767.
  5. Okayasu K, Kawasaki T, Kumagai J, Miyazaki Y. Clinicoradiological course of abemaciclib-induced pneumonitis with histology findings. BMJ Case Rep. 2023 05;16(5):e254349.
  6. Shi J, Shiraishi K, Choi J, Matsuo K, Chen TY, Dai J, Hung RJ, Chen K, Shu XO, Kim YT, Landi MT, Lin D, Zheng W, Yin Z, Zhou B, Song B, Wang J, Seow WJ, Song L, Chang IS, Hu W, Chien LH, Cai Q, Hong YC, Kim HN, Wu YL, Wong MP, Richardson BD, Funderburk KM, Li S, Zhang T, Breeze C, Wang Z, Blechter B, Bassig BA, Kim JH, Albanes D, Wong JYY, Shin MH, Chung LP, Yang Y, An SJ, Zheng H, Yatabe Y, Zhang XC, Kim YC, Caporaso NE, Chang J, Ho JCM, Kubo M, Daigo Y, Song M, Momozawa Y, Kamatani Y, Kobayashi M, Okubo K, Honda T, Hosgood DH, Kunitoh H, Patel H, Watanabe SI, Miyagi Y, Nakayama H, Matsumoto S, Horinouchi H, Tsuboi M, Hamamoto R, Goto K, Ohe Y, Takahashi A, Goto A, Minamiya Y, Hara M, Nishida Y, Takeuchi K, Wakai K, Matsuda K, Murakami Y, Shimizu K, Suzuki H, Saito M, Ohtaki Y, Tanaka K, Wu T, Wei F, Dai H, Machiela MJ, Su J, Kim YH, Oh IJ, Lee VHF, Chang GC, Tsai YH, Chen KY, Huang MS, Su WC, Chen YM, Seow A, Park JY, Kweon SS, Chen KC, Gao YT, Qian B, Wu C, Lu D, Liu J, Schwartz AG, Houlston R, Spitz MR, Gorlov IP, Wu X, Yang P, Lam S, Tardon A, Chen C, Bojesen SE, Johansson M, Risch A, Bickeböller H, Ji BT, Wichmann HE, Christiani DC, Rennert G, Arnold S, Brennan P, McKay J, Field JK, Shete SS, Le Marchand L, Liu G, Andrew A, Kiemeney LA, Zienolddiny-Narui S, Grankvist K, Johansson M, Cox A, Taylor F, Yuan JM, Lazarus P, Schabath MB, Aldrich MC, Jeon HS, Jiang SS, Sung JS, Chen CH, Hsiao CF, Jung YJ, Guo H, Hu Z, Burdett L, Yeager M, Hutchinson A, Hicks B, Liu J, Zhu B, Berndt SI, Wu W, Wang J, Li Y, Choi JE, Park KH, Sung SW, Liu L, Kang CH, Wang WC, Xu J, Guan P, Tan W, Yu CJ, Yang G, Sihoe ADL, Chen Y, Choi YY, Kim JS, Yoon HI, Park IK, Xu P, He Q, Wang CL, Hung HH, Vermeulen RCH, Cheng I, Wu J, Lim WY, Tsai FY, Chan JKC, Li J, Chen H, Lin HC, Jin L, Liu J, Sawada N, Yamaji T, Wyatt K, Li SA, Ma H, Zhu M, Wang Z, Cheng S, Li X, Ren Y, Chao A, Iwasaki M, Zhu J, Jiang G, Fei K, Wu G, Chen CY, Chen CJ, Yang PC, Yu J, Stevens VL, Fraumeni JF Jr, Chatterjee N, Gorlova OY, Hsiung CA, Amos CI, Shen H, Chanock SJ, Rothman N, Kohno T, Lan Q. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population. Nat Commun. 2023 05;14(1):3043.
  7. Kaneko S, Asahina Y, Nakagawa M, Murakawa M, Miyazaki Y, Asakage T, Fukuda S, Namiki T, Kano Y, Nagata M, Tsuchiya J, Miyoshi M, Kitahata-Kawai F, Nitta S, Itsui Y, Kakinuma S, Okamoto R: Factors associated with liver injury and prognosis in advanced cancer patients treated with immune checkpoint inhibitors. Hepatology Research. 2023.05; 53 (5): 450-459.
  8. Hosoya T, Oba S, Komiya Y, Kawata D, Kamiya M, Iwai H, Miyamoto S, Kataoka M, Tobiume M, Kanno T, Ainai A, Sato H, Hirakawa A, Mitsui Y, Satoh T, Wakabayashi K, Yamada T, Otomo Y, Miyazaki Y, Hasegawa H, Suzuki T, Yasuda S: Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19. Proceedings of the National Academy of Sciences of the United States of America. 2023.05; 120 (22): e2300155120.
  9. Yin Y, Sakakibara R, Honda T, Kirimura S, Daroonpan P, Kobayashi M, Ando K, Ujiie H, Kato T, Kaga K, Mitsumura T, Nakano R, Sakashita H, Matsuge S, Ishibashi H, Akashi T, Hida Y, Morohoshi T, Azuma M, Okubo K, Miyazaki Y. High density and proximity of CD8+ T cells to tumor cells are correlated with better response to nivolumab treatment in metastatic pleural mesothelioma. Thorac Cancer. 2023 07;14(20):1991-2000.
  10. Kawamoto Y, Yatomi Y, Furusawa H, Hanzawa S, Miyazaki Y, Tanaka M. Understanding the process of people with hypersensitivity pneumonitis implementing continuous antigen avoidance and their affecting situations: A grounded theory study. J Clin Nurs. 2023 06;32(11-12):2880-2891.
  11. Nishioka Y, Homma S, Ogura T, Sato S, Arai N, Tomii K, Kamio K, Sakamoto S, Miyazaki Y, Tomioka H, Hisata S, Handa T, Azuma A. Exploratory phase 2 study of the novel oral multi-kinase inhibitor TAS-115 in patients with idiopathic pulmonary fibrosis. Respir Investig. 2023 07;61(4):498-507.
  12. Shirai T, Tanino Y, Nikaido T, Takaku Y, Hashimoto S, Taguchi Y, Baba T, Ogura T, Kataoka K, Nakayama M, Yamada Y, Matsushima S, Minami K, Miyazaki Y. Utility of budgerigar/pigeon/parrot-specific IgG antibody with ImmunoCAP® in bird-related hypersensitivity pneumonitis caused by other bird species and duvet. Respir Investig. 2023 07;61(4):520-526.
  13. Mitsui Y, Suzuki T, Kuniyoshi K, Inamo J, Yamaguchi K, Komuro M, Watanabe J, Edamoto M, Li S, Kouno T, Oba S, Hosoya T, Masuhiro K, Naito Y, Koyama S, Sakaguchi N, Standley DM, Shin JW, Akira S, Yasuda S, Miyazaki Y, Kochi Y, Kumanogoh A, Okamoto T, Satoh T. Expression of the readthrough transcript CiDRE in alveolar macrophages boosts SARS-CoV-2 susceptibility and promotes COVID-19 severity. Immunity. 2023 08;56(8):1939-1954.e12.
  14. Kataoka K, Oda K, Takizawa H, Ogura T, Miyamoto A, Inoue Y, Akagawa S, Hashimoto S, Kishaba T, Sakamoto K, Hamada N, Kuwano K, Nakayama M, Ebina M, Enomoto N, Miyazaki Y, Atsumi K, Izumi S, Tanino Y, Ishii H, Ohnishi H, Suda T, Kondoh Y. Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy. Sci Rep. 2023 08;13(1):13664.
  15. Igarashi T, Mazevet M, Yasuhara T, Yano K, Mochizuki A, Nishino M, Yoshida T, Yoshida Y, Takamatsu N, Yoshimi A, Shiraishi K, Horinouchi H, Kohno T, Hamamoto R, Adachi J, Zou L, Shiotani B. An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stress. Nat Commun. 2023 08;14:4991.
  16. Endo S, Honda T, Sato K, Kubota N, Kamoshida T, Mochizuki A, Fujii M, Ochi J, Miyazaki Y, Tsukada Y. Evaluating the potential of immunotherapy and chemoimmunotherapy in the treatment of elderly non-small cell lung cancer patients: A real-world study. Cancer Treat Res Commun. 2023;37:100755.
  17. COVID-19 Host Genetics Initiative. A second update on mapping the human genetic architecture of COVID-19. Nature. 2023 09;621(7977):E7-E26.
  18. Saito S, Kutsuna S, Akifumi I, Hase R, Oda R, Terada J, Shimizu Y, Uemura Y, Takamatsu Y, Yasuhara A, Shiratori K, Satake M, Sakamoto N, Miyazaki Y, Shimizu H, Togano T, Matsunaga A, Okuma K, Hamaguchi I, Fujisawa K, Nagashima M, Ashida S, Terada M, Kimura A, Morioka S, Matsubayashi K, Tsuno NH, Kojima M, Kuramitsu M, Tezuka K, Ikebe E, Ishizaka Y, Kenji M, Hangaishi A, Mikami A, Sugiura W, Ohmagari N, Mitsuya H. Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial. J Infect Chemother. 2023 09;29(9):869-874.
  19. Honda T, Seto K, Endo S, Takemoto A, Tanimoto K, Kobayashi M, Kitano M, Sakakibara R, Mitsumura T, Ishibashi H, Inazawa J, Tanaka T, Miyazaki Y, Okubo K. The possibility of mutations of RAS signaling genes and/or TP53 in combination as a negative prognostic impact on pathological stage I non-small cell lung cancer. Cancer Med. 2023 10;12(19):19406-19413.
  20. Oba S, Hosoya T, Kaneshige R, Kawata D, Yamaguchi T, Mitsumura T, Shimada S, Shibata S, Tateishi T, Koike R, Tohda S, Hirakawa A, Yoko N, Otomo Y, Nojima J, Miyazaki Y, Yasuda S. Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching. Front Immunol. 2023 10;14:1227547.
  21. Okada K, Sakakibara R, Honda T, Mitsumura T, Shibata S, Shirai T, Okamoto T, Furusawa H, Tateishi T, Miyazaki Y. Tolerability of sotorasib for KRAS positive lung adenocarcinoma patient with pre-existing interstitial pneumonia; A case report. Respir Med Case Rep. 2023 10;46:101929.
  22. Hosokawa, M; Mikawa, R; Hagiwara, A; Okuno, Y; Awaya, T; Yamamoto, Y; Takahashi, S; Yamaki, H; Osawa, M; Setoguchi, Y; Saito, MK; Abe, S; Hirai, T; Gotoh, S; Hagiwara, M: Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC. ISCIENCE. 2023.10; 26 (10).
  23. Shimasaki S, Baba T, Ogura T, Akasaka K, Matsushima H, Izumi S, Takasaki J, Tsushima K, Kinouchi T, Kichikawa Y, Awashima M, Izumo T, Awano N, Nishimura N, Tazawa R, Mikami A, Kitamura N, Ishii H, Kurihara Y, Taniguchi M, Aikawa S, Okada M, Morita Y, Ishikawa Y, Ohinata A, Nakata K. Short-term inhalation of sargramostim with concomitant high-dose steroids does not hasten recovery in moderate COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial. Infect Dis (Lond). 2023 12;55(12):857-873.
  24. Ando T, Shimada S, Sugihara J, Takayama K, Kobayashi M, Miyashita Y, Ito T, Okayasu K, Tsuyuki S, Ohba T, Doi M, Saito H, Fujie T, Chiaki T, Nakagawa A, Anzai T, Takahashi K, Shibata S, Tateishi T, Miyazaki Y. Impairment of Social-Related Quality of Life in COVID-19 Pneumonia Survivors: A Prospective Longitudinal Study. Journal of Clinical Medicine. 2023.12;12:7640
  25. Kondo N, Utsumi T, Shimizu Y, Takemoto A, Oh-Hara T, Uchibori K, Subat-Motoshi S, Ninomiya H, Takeuchi K, Nishio M, Miyazaki Y, Katayama R. MIG6 loss confers resistance to ALK/ROS1 inhibitors in NSCLC through EGFR activation by low-dose EGF. JCI Insight. 2023 12 22;8(24):e173688.
  26. Funaita C, Furuie W, Koike F, Oyama S, Endo J, Otani Y, Ichikawa Y, Ito M, Nakamura Y, Komatuzaki K, Hirata A, Miyazaki Y, Sumi Y. Pattern recognition of forced oscillation technique measurement results using deep learning can identify asthmatic patients more accurately than setting reference ranges. Sci Rep. 2023 12;13(1):21608.
  27. Okamoto M, Fujimoto K, Johkoh T, Kawaguchi A, Mukae H, Sakamoto N, Ogura T, Ikeda S, Kondoh Y, Yamano Y, Komiya K, Umeki K, Nishikiori H, Tanino Y, Tsuda T, Arai N, Komatsu M, Sakamoto S, Yatera K, Inoue Y, Miyazaki Y, Hashimoto S, Shimizu Y, Hozumi H, Ohnishi H, Handa T, Hattori N, Kishaba T, Kato M, Inomata M, Ishii H, Hamada N, Konno S, Zaizen Y, Azuma A, Suda T, Izuhara K, Hoshino T. A prospective cohort study of periostin as a serum biomarker in patients with idiopathic pulmonary fibrosis treated with nintedanib. Sci Rep. 2023 12;13(1):22977.
  28. Aoki H, Miyazaki Y, Anzai T, Yokoyama K, Tsuchiya J, Shirai T, Shibata S, Sakakibara R, Mitsumura T, Honda T, Furusawa H, Okamoto T, Tateishi T, Tamaoka M, Yamamoto M, Takahashi K, Tateishi U, Yamaguchi T. Deep convolutional neural network for differentiating between sarcoidosis and lymphoma based on [18F]FDG maximum-intensity projection images. Eur Radiol. 2024 01;34(1):374-383.
  29. Tomioka H, Miyazaki Y, Inoue Y, Egashira R, Kawamura T, Sano H, Johkoh T, Takemura T, Hisada T, Fukuoka J; committee of Japanese Respiratory Society for Japanese clinical practice guide 2022 for hypersensitivity pneumonitis. Japanese clinical practice guide 2022 for hypersensitivity pneumonitis. Respir Investig. 2024 01;62(1):16-43.
  30. Endo S, Okamoto T, Kawahara T, Anzai T, Takahashi K, Miyazaki Y. Effect of warm and humid days on the positivity rate of anti-Trichosporon asahii antibody test for the diagnosis of summer-type hypersensitivity pneumonitis. Respir Investig. 2024 01;62(1):150-156.
  31. Hirai T, Asano K, Ito I, Miyazaki Y, Sugiura H, Agirbasli M, Kobayashi S, Kobayashi M, Shimada D, Natsume I, Kawasaki T, Ohba T, Tajiri S, Sakamaki F, Mineshita M, Takihara T, Sekiya K, Tomii K, Tomioka H, Kita H, Nishizaka Y, Fukui M, Miyata T, Harigae H. A randomized double-blind placebo-controlled trial of an inhibitor of plasminogen activator inhibitor-1 (TM5614) in mild to moderate COVID-19. Sci Rep. 2024 01;14(1):165.
  32. Shiraishi K, Takahashi A, Momozawa Y, Daigo Y, Kaneko S, Kawaguchi T, Kunitoh H, Matsumoto S, Horinouchi H, Goto A, Honda T, Shimizu K, Torasawa M, Takayanagi D, Saito M, Saito A, Ohe Y, Watanabe SI, Goto K, Tsuboi M, Tsuchihara K, Takata S, Aoi T, Takano A, Kobayashi M, Miyagi Y, Tanaka K, Suzuki H, Maeda D, Yamaura T, Matsuda M, Shimada Y, Mizuno T, Sakamoto H, Yoshida T, Goto Y, Yoshida T, Yamaji T, Sonobe M, Toyooka S, Yoneda K, Masago K, Tanaka F, Hara M, Fuse N, Nishizuka SS, Motoi N, Sawada N, Nishida Y, Kumada K, Takeuchi K, Tanno K, Yatabe Y, Sunami K, Hishida T, Miyazaki Y, Ito H, Amemiya M, Totsuka H, Nakayama H, Yokose T, Ishigaki K, Nagashima T, Ohtaki Y, Imai K, Takasawa K, Minamiya Y, Kobayashi K, Okubo K, Wakai K, Shimizu A, Yamamoto M, Iwasaki M, Matsuda K, Inazawa J, Shiraishi Y, Nishikawa H, Murakami Y, Kubo M, Matsuda F, Kamatani Y, Hamamoto R, Matsuo K, Kohno T. Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome-wide association and whole genome sequencing analyses. Cancer Commun (Lond). 2024 02;44(2):287-293.
  33. Iijima Y, Ejima M, Yamana T, Sonoda S, Shibata S, Shirai T, Okamoto T, Furusawa H, Tateishi T, Adachi T, Mori M, Kirimura S, Anzai T, Takahashi K, Miyazaki Y. Assessment of clinical relevance of antigen improves diagnostic accuracy of hypersensitivity pneumonitis. BMC Pulm Med. 2024 02;24(1):84.
  34. Mochizuki A, Shiraishi K, Honda T, Higashiyama RI, Sunami K, Matsuda M, Shimada Y, Miyazaki Y, Yoshida Y, Watanabe SI, Yatabe Y, Hamamoto R, Kohno T. Passive Smoking-Induced Mutagenesis as a Promoter of Lung Carcinogenesis. J Thorac Oncol. 2024 02:S1556-0864(24)00074-1.
  35. Yasui S, Honda T, Onishi I, Ikeda S, Miyazaki Y. Effective Treatment of Lung Adenocarcinoma With a Novel SLC44A1-BRAF Fusion Using Pembrolizumab Followed by Trametinib: A Case Report. Cureus. 2024 02;16(2):e54739.
  36. Kubota N, Okamoto T, Shimada S, Yamana T, Iijima Y, Sakakibara R, Shibata S, Honda T, Mitsumura T, Shirai T, Furusawa H, Tateishi T, Adachi T, Kirimura S, Miyazaki Y: A Case of Solitary Pure Ground-glass Opacity Suspected of Being the Initial Presentation of Nonfibrotic Hypersensitivity Pneumonitis. Internal medicine. 2024.02.
  37. Matsubara Y, Kiyohara H, Mikami Y, Nanki K, Namkoong H, Chubachi S, Tanaka H, Azekawa S, Sugimoto S, Yoshimatsu Y, Sujino T, Takabayashi K, Hosoe N, Sato T, Ishii M, Hasegawa N, Okada Y, Koike R, Kitagawa Y, Kimura A, Imoto S, Miyano S, Ogawa S, Fukunaga K, Kanai T; Japan COVID-19 Task Force. Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study. J Gastroenterol. 2024 03;59(3):195-208.
  38. Shimada S, Yamaguchi T, Mikoshiba S, Sato K, Mitsumura T, Komori K, Yamana T, Iijima Y, Sakakibara R, Shibata S, Honda T, Shirai T, Okamoto T, Furusawa H, Tateishi T, Miyazaki Y. Relapsing bronchopneumonia due to community-associated methicillin-resistant Staphylococcus aureus: a case report. BMC Infectious Diseases. 2024.3; 24: 374.
  39. Isobe K, Nakamura Y, Sakamoto S, Tomii K, Takimoto T, Miyazaki Y, Matsumoto M, Sugino K, Ichikado K, Moriguchi S, Yamaguchi K, Baba T, Ozasa H, Igata F, Anabuki K, Homma S, Date H, Suda T, Kishi K: Immune checkpoint inhibitors in patients with lung cancer having chronic interstitial pneumonia. ERJ open research. 2024.03; 10 (2).
  40. Kamata H, Takamatsu K, Fukunaga K, Chubachi S, Nakagawara K, Namkoong H, Terai H, Tanaka K, Sato S, Hagiwara E, Takei R, Kondoh Y, Takazono T, Hashimoto M, Tasaka S, Ohrui T, Tanino Y, Mineshita M, Komase Y, Miyazaki K, Nishikawa M, Ando A, Kita H, Ichihara E, Ohshimo S, Murata Y, Ishida M, Kobayashi S, Uchida T, Tateno H, Ikari J, Terashima T, Kozu Y, Tateishi T, Shinkai M, Sagara H, To Y, Ito Y, Yamamoto M, Yamamoto Y, Kita T, Ito Y, Tomii K, Fujita Y, Funaki Y, Yatera K, Yamasue M, Komiya K, Kozawa S, Manabe H, Hozumi H, Horiguchi T, Kitajima T, Nakano Y, Nagaoka T, Hojo M, Ebihara A, Kobayashi M, Takayama K, Jinta T, Sawai T, Fukuda Y, Kaneko T, Chin K, Ogura T, Mukae H, Ishii M, Yokoyama A. Pulmonary function and chest CT abnormalities 3 months after discharge from COVID-19, 2020-2021: A nation-wide multicenter prospective cohort study from the Japanese respiratory society. Respir Investig. 2024 04;62(4):572-579.
  41. Maruyama S, Furusawa H, Endo S, Kumagai T, Mitsumura T, Shimada S, Yamana T, Sakakibara R, Iijima Y, Shibata S, Honda T, Shirai T, Okamoto T, Tateishi T, Tamaoka M, Kinowaki Y, Ishibashi H, Okubo K, Miyazaki Y. Pulmonary Artery Aneurysm in a Patient with Nontuberculous Mycobacteria Infection. Intern Med. 2024 04;63(7):989-992.
  42. Komatsuzaki K, Kageshima H, Sekino Y, Suzuki Y, Ugajin T, Tamaoka M, Hanazawa R, Hirakawa A, Miyazaki Y. Local nasal immunotherapy with birch pollen-galactomannan conjugate-containing ointment in mice and humans. Allergol Int. 2024 04;73(2):290-301.
  43. Hanzawa S, Sugiura M, Nakae S, Masuo M, Morita H, Matsumoto K, Takeda K, Okumura K, Nakamura M, Ohno T, Miyazaki Y: The Prostaglandin D2 Receptor CRTH2 Contributes to Airway Hyperresponsiveness during Airway Inflammation Induced by Sensitization without an Adjuvant in Mice. International archives of allergy and immunology. 2024.04; 1-9.
  44. Goto Y, Nagamine Y, Hanafusa M, Kawahara T, Nawa N, Tateishi U, Ueki Y, Miyamae S, Wakabayashi K, Nosaka N, Miyazaki Y, Tohda S, Fujiwara T. Association of excess visceral fat and severe illness in hospitalized COVID-19 patients in Japan: a retrospective cohort study. Int J Obes (Lond). 2024 05;48(5):674-682.
  45. Bando M, Homma S, Date H, Kishi K, Yamauchi H, Sakamoto S, Miyamoto A, Goto Y, Nakayama T, Azuma A, Kondoh Y, Johkoh T, Nishioka Y, Fukuoka J, Miyazaki Y, Yoshino I, Suda T; Ministry of Health, Labour and Welfare, the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on Intractable Diseases, and Japanese Respiratory Society. Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023: Revised edition. Respir Investig. 2024 05;62(3):402-418.
  46. Shimada S, Nakai R, Aoki K, Miura S, Komori K, Kudoh S, Imura S, Ishii Y, Tateda K. Complete Genome Sequence of Polynucleobacter sp. Strain TUM22923, Isolated from Antarctic Lake Sediment. Microbiology resource announcement. 2024.6; 12(7).
  47. Kitano M, Honda T, Hikita E, Masuo M, Miyazaki Y, Kobayashi M. Delayed immune-related adverse events in long-responders of immunotherapy: a single-center experience. Asia Pac J Clin Oncol. 2024 Epub ahead of print.

原著論文(和文)

  1. 高澤聖子, 岡本師, 細谷龍作, 榊原里江, 石塚聖洋, 宮崎泰成: CEAが異常高値を呈した嚢胞を伴う濾胞性細気管支炎の1例 日本呼吸器学会誌. 2023.05; 12 (3): 154-159.
  2. 丸山総一, 髙橋太郎, 早瀬ヨネ子, 小林大輔, 本多隆行, 杉山幸比古. タクロリムス使用中に急速増大したROS1融合遺伝子陽性肺腺癌の1例. 日呼吸誌. 2023;12(4): 210-214.
  3. 望月晶史, 本多隆行, 白石航也, 吉田幸弘, 渡辺俊一, 堀之内秀仁, 谷田部恭, 浜本隆二, 宮崎泰成, 河野隆志. 肺発生系譜上の転写因子TTF-1/NKX2-1の変異と間質性肺炎合併肺腺がんの関連性. 日本肺サーファクタント・界面医学会雑誌. 2023 08;54:24-26.

著書

  1. 島田翔. 症例から学ぶ「過敏性肺炎診療指針の使い方」第1部 診断 第3章 住居関連過敏性肺炎 3 環境調査の方法. 2024.3; 53-61

商業誌

  1. 宮崎 泰成, 飯島 裕基, 惠島 將, 白井 剛: 【一般臨床医が知っておくべき過敏性肺炎】 日本医事新報. 2023.04; (5166): 18-37.
  2. 飯島 裕基, 宮崎 泰成: 【在宅でみる呼吸器疾患のリハビリテーション診療】過敏性肺炎における呼吸器リハビリテーション MEDICAL REHABILITATION. 2023.04; (286): 55-58.
  3. 立石知也. 過敏性肺炎臨床update 職業・環境による曝露の評価を中心に. 日本職業・環境アレルギー学会雑誌. 2023 05;30(2):29.
  4. 宮崎 泰成, 須田 隆文: 呼吸器内科 過敏性肺炎の診断のポイントについて【(1)曝露評価が重要,(2)抗原の大きさが3~5μm,呼吸細気管支領域に病変ができる,(3)進行すると特発性肺線維症と鑑別困難,経時的な画像で診断】 日本医事新報. 2023.06; (5173): 56.
  5. 浅野 浩一郎, 宮崎 泰成: 呼吸器内科 室内環境と気管支喘息の関連について【小児喘息ではダニ,成人喘息では真菌が重要な室内環境アレルゲンである】 日本医事新報. 2023.08; (5180): 46.
  6. 田澤立之. 【ガイドラインから見るびまん性肺疾患診療の進歩】肺胞蛋白症診療ガイドライン2022 治療の進歩. 呼吸器内科. 2023;44(3):249-254.
  7. 本多隆行,望月晶史、河野隆志、宮崎泰成. 話題 間質性肺炎合併肺がんの発症機構. 呼吸器内科. 2023;44(3).
  8. 岡本師, 宮崎泰成. COVID-19とILD診療. 呼吸器内科. 2023;44:691.
  9. 丸山総一, 岡本師, 柴田翔, 本多隆行, 白井剛, 古澤春彦, 立石知也, 玉岡明洋, 宮崎泰成. 進行性線維化を伴う間質性肺疾患におけるニンテダニブ投与量の違いによる安全性と有効性. 呼吸臨床. 2023;7(4).
  10. 立石知也. 過敏性肺炎の診断update 国際ガイドラインと本邦の診療指針をどのように考えるか. 日本サルコイドーシス/肉芽腫性疾患学会雑誌.  2023 10 43(1-2):77.
  11. 立石知也. 【間質性肺疾患の急性増悪をとらえなおす】急性増悪の臨床病態と予後 線維性過敏性肺炎とその他ILD. 呼吸器内科. 2024 01;45(1):24.
  12. 岡本師, 大谷義夫. 症例から学ぶ『過敏性肺炎診療指針』の使い方 かかりつけ医の役割. 2024.03
  13. 島田翔. 【特集:南極観測における医療と医学研究】昭和基地における感染対策とレジオネラ研究. 極地. 2024.03; 60(1): 24-27.
  14. 柴田翔.【気管支喘息に罹患しています。強く息を吐くとヒューヒューするのはわかりますが、まったく息苦しさはありません。治療を続けなくてはならないでしょうか?】臨床雑誌内科. 2024.04;133.578-580.
  15. 小松崎恵子.【喘息の検査でアレルギー検査をしてもらったら, キウイなどの食べ物も陽性と出てしまいました. こういった食べ物はもう食べないほうがよいでしょうか?】臨床雑誌内科. 2024.04;133.584-586.
  16. 岡本 師: 【患者さんからよく尋ねられる内科診療のQuestion】(第2章)呼吸器 [56歳男性,間質性肺炎疑い,鳥特異的IgG陽性]過敏性肺炎の可能性があると言われました.生活環境にどこまで気をつけるべきでしょうか? 内科. 2024.04; 133 (4): 626-628.

2022年業績

原著論文(英文)

  1. Mitsumura T, Okamoto T, Tosaka M, Yamana T, Shimada S, Iijima Y, Sakakibara R, Shibata S, Honda T, Shirai T, Ishizuka M, Aiboshi J, Furusawa H, Tateishi T, Tamaoka M, Shigemitsu H, Arai H, Otomo Y, Tohda S, Anzai T, Takahashi K, Yasuda S, Miyazaki Y. SARS-CoV-2 RNA copy number is a factor associated with the mortality of COVID-19 and improves the predictive performance of mortality in severe cases. Japanese journal of infectious diseases. 2022.05; 75 (5): 504-510.
  2. Ejima M, Okamoto T, Suzuki T, Miyazaki Y. Role of serum surfactant protein-D as a prognostic predictor in fibrotic hypersensitivity pneumonitis. Respir Investig. 2022.05; 60(3): 369-378.
  3. Kawamoto Y, Yatomi Y, Furusawa H, Hanzawa S, Miyazaki Y, Tanaka M. Understanding the process of people with hypersensitivity pneumonitis Implementing continuous antigen avoidance and their affecting situations: A grounded theory study. Journal of Clinical Nursing. 2022.06; 32 (11-12): 2880-2891.
  4. Ikeda T, Ichiba S, Sasaki T, Sato M, Konoeda C, Okamoto T, Miyazaki Y, Nakajima J, Sakamoto A. A case of severe respiratory failure due to interstitial pneumonia successfully bridged to lung transplantation from a brain-dead donor using 109-day veno-arterial extracorporeal membrane oxygenation. Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs. 2022.06; 26 (1): 84-88.
  5. Komatsu M, Yamamoto H, Matsui S, Terasaki Y, Hebisawa A, Iwasawa T, Johkoh T, Baba T, Miyamoto A, Handa T, Tomii K, Waseda Y, Bando M, Ishii H, Miyazaki Y, Yoshizawa A, Takemura T, Kawabata Y, Hanaoka M, Ogura T, Tokyo Diffuse Lung Disease Study Group.. Respiratory lesions in IgG4-related disease: classification using 2019 American College of Rheumatology/European League Against Rheumatism criteria. ERJ open research. 2022.07; 8 (3): 00120-2022.
  6. Mitsumura T, Okamoto T, Tosaka M, Yamana T, Shimada S, Iijima Y, Sakakibara R, Shibata S, Honda T, Shirai T, Ishizuka M, Aiboshi J, Furusawa H, Tateishi T, Tamaoka M, Shigemitsu H, Arai H, Otomo Y, Tohda S, Anzai T, Takahashi K, Yasuda S, Miyazaki Y. Association of SARS-CoV-2 RNA Copy Number with the COVID-19 Mortality Rate and Its Effect on the Predictive Performance of Mortality in Severe Cases. Jpn J Infect Dis. 2022.09; 75(5): 504-510.
  7. Okamoto T, Dobrinskikh E, Hennessy CE, Liu N, Schwarz MI, Evans CM, Fontenot AP, Yang IV, Schwartz DA. Muc5b plays a role in the development of inflammation and fibrosis in hypersensitivity pneumonitis induced by Saccharopolyspora rectivirgula. Am J Physiol Lung Cell Mol Physiol. 2022.09; 323(3): L329-L337.
  8. Okuda R, Ogura T, Hisata S, Baba T, Kondoh Y, Suda T, Johkoh T, Iwasawa T, Tomioka H, Bando M, Azuma A, Inoue Y, Arai T, Nakamura Y, Miyamoto A, Miyazaki Y, Chiba H, Ishii H, Hamada N, Terasaki Y, Kuwahira I, Sato S, Kato S, Suzuki T, Sakamoto S, Nishioka Y, Hattori N, Hashimoto N, Morita S, Ichihara N, Miyata H, Hagiwara K, Nukiwa T, Kobayashi K. Design and rationale of the Japanese Idiopathic Interstitial Pneumonias (JIPS) Registry. Respiratory investigation. 2023.01; 61 (1): 95-102.
  9. Kaneko S, Asahina Y, Nakagawa M, Murakawa M, Miyazaki Y, Asakage T, Fukuda S, Namiki T, Kano Y, Nagata M, Tsuchiya J, Miyoshi M, Kitahata-Kawai F, Nitta S, Itsui Y, Kakinuma S, Okamoto R. Factors associated with liver injury and prognosis in advanced cancer patients treated with immune checkpoint inhibitors. Hepatology research : the official journal of the Japan Society of Hepatology. 2023.01; 53 (5): 450-459.
  10. Peljto AL, Blumhagen RZ, Walts AD, Cardwell J, Powers J, Corte TJ, Dickinson JL, Glaspole I, Moodley YP, Vasakova MK, Bendstrup E, Davidsen JR, Borie R, Crestani B, Dieude P, Bonella F, Costabel U, Gudmundsson G, Donnelly SC, Egan J, Henry MT, Keane MP, Kennedy MP, McCarthy C, McElroy AN, Olaniyi JA, O'Reilly KMA, Richeldi L, Leone PM, Poletti V, Puppo F, Tomassetti S, Luzzi V, Kokturk N, Mogulkoc N, Fiddler CA, Hirani N, Jenkins G, Maher TM, Molyneaux PL, Parfrey H, Braybrooke R, Blackwell TS, Jackson PD, Nathan SD, Porteous MK, Brown KK, Christie JD, Collard HR, Eickelberg O, Foster EE, Gibson KF, Glassberg M, Kass D, Kropski JA, Lederer D, Linderholm AL, Loyd J, Mathai SK, Montesi SB, Noth I, Oldham JM, Palmisciano AJ, Reichner CA, Rojas M, Roman J, Schluger N, Shea BS, Swigris JJ, Wolters PJ, Zhang Y, Prele CMA, Enghelmayer JI, Otaola M, Ryerson CJ, Salinas M, Sterclova M, Gebremariam TH, Myllärniemi M, Carbone R, Furusawa H, Hirose M, Inoue Y, Miyazaki Y, Ohta K, Ohta S, Okamoto T, Kim DS, Pardo A, Selman M, Aranda AU, Park MS, Park JS, Song JW, Molina-Molina M, Planas-Cerezales L, Westergren-Thorsson G, Smith AV, Manichaikul AW, Kim JS, Rich SS, Oelsner EC, Barr RG, Rotter JI, Dupuis J, O'Connor G, Vasan RS, Cho MH, Silverman EK, Schwarz MI, Steele MP, Lee JS, Yang IV, Fingerlin TE, Schwartz DA, NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium. Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants. American journal of respiratory and critical care medicine. 2023.01; 207 (9): 1194-1202.
  11. Ikeda M, Okugawa S, Kashiwabara K, Moritoyo T, Kanno Y, Jubishi D, Hashimoto H, Okamoto K, Tsushima K, Uchida Y, Mitsumura T, Igari H, Tsutsumi T, Araoka H, Yatera K, Yamamoto Y, Nakamura Y, Otani A, Yamashita M, Wakimoto Y, Shinohara T, Adachi-Katayama M, Oyabu T, Kanematsu A, Harada S, Takeshita Y, Nakano Y, Miyazaki Y, Sakao S, Saito M, Ogura S, Yamasaki K, Kawasuji H, Hataji O, Inoue JI, Seto Y, Moriya K. Multicenter, Single-Blind, Randomized Controlled Study of the Efficacy and Safety of Favipiravir and Nafamostat Mesilate in Patients with COVID-19 Pneumonia. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2023.01; 128 355-363.
  12. Yamashita S, Okamoto T, Kawahara T, Tateishi T, Anzai T, Takahashi K, Fushimi K, Miyazaki Y. Database analysis of hypersensitivity pneumonitis in Japan. Respiratory investigation. 2023.01; 61 (2): 172-180.
  13. Tateishi T, Shimada S, Yamana T, Iijima Y, Sakakibara R, Mitsumura T, Shibata S, Honda T, Shirai T, Okamoto T, Tamaoka M, Sasai T, Miyazaki Y. COVID-19 Pneumonia Followed by Anti-signal Recognition Particle Antibody-positive Fibrosing Interstitial Lung Disease: A Case Report. Internal medicine (Tokyo, Japan). 2023.02; 62 (9): 1323-1328.
  14. Umezawa N, Sasaki H, Furusawa H, Kawata D, Hata C, Yasuda S. Development of vasculitis in a case with severe asthma treated with benralizumab and low-dose corticosteroid. Allergol Int. 2022.09; 1 (72): 179-181.
  15. Sakashita H, Uchibori K, Jin Y, Tsutsui T, Honda T, Sakakibara R, Mitsumura T, Nukui Y, Shirai T, Masuo M, Suhara K, Furusawa H, Yamashita T, Ohba T, Saito K, Takagiwa J, Miyashita Y, Inase N, Miyazaki Y. A phase II feasibility study of carboplatin and nab-paclitaxel for advanced non-small cell lung cancer patients with interstitial lung disease (YLOG0114). Thorac Cancer. 2022.05; 13 (9): 1267-1275.
  16. Minegishi Y, Akagami T, Arai M, Saito R, Arai D, Murase K, Miura K, Watanabe S, Sakashita H, Miyabayashi T, Honda R, Jingu D, Hotta T, Isobe K, Nakazawa K, Ito K, Takamura K, Inomata M, Harada T, Sakakibara R, Nakagawa T, Shibuya H, Takenaka K, Kobayashi K, Seike M. Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042). Lung Cancer. 2022.10; 172: 1-8.
  17. Namkoong H, et al. DOCK2 is involved in the host genetics and biology of severe COVID-19. Nature. 2022.11; 609 (7928): 754-760.
  18. Wang QS, et al. The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force. Nat Commun. 2022.08; 13 (1): 4830.
  19. Tateishi T. Do we still live under a silica rock? Ann Palliat Med. 2022.07; 11 (7): 2191-2193.
  20. Suzuki T, Okamoto T, Akiyama M, Honda T, Ejima M, Ishizuka M, Sakashita H, Miyazaki Y. Cumulative Incidences of Lung Cancer in Various Interstitial Lung Diseases. J Med Dent Sci. 2022.11; 69: 11-19.
  21. Kubota-Miyazawa A, Sugimoto K, Miyazaki Y, Sakurai Y, Oki M, Suzuki H, Yoshida N. J Med Dent Sci. 2022.11; 69: 21-28.
  22. Oda M, Yamaura K, Ishii H, Kitamura N, Tazawa R, Abe M, Tatsumi K, Eda R, Kondoh S, Morimoto K, Tanaka T, Yamaguchi E, Takahashi A, Izumi S, Sugiyama H, Nakagawa A, Tomii K, Suzuki M, Konno S, Ohkouchi S, Tode N, Handa T, Hirai T, Inoue Y, Arai T, Asakawa K, Tanaka T, Takada T, Nonaka H, Nakata K. Quantitative Evaluation of Changes in Three-Dimensional CT Density Distributions in Pulmonary Alveolar Proteinosis after GM-CSF Inhalation. Respiration. 2023.02; 102 (2): 101-109.
  23. Papiris SA, Campo I, Mariani F, Kallieri M, Kolilekas L, Papaioannou AI, Gonca Chousein E, Cetinkaya E, Bonella F, Borie R, Kokosi M, Pickworth T, Molina-Molina M, Gasa M, Radzikowska E, Fijolek J, Jouneau S, Gomez E, McCarthy C, Bendstrup E, Piotrowski WJ, Pabary R, Hadchouel A, Coolen-Allou N, Alfaro T, Robalo Cordeiro C, Antonogiannaki EM, Tomos IP, Papakosta D, Kontakiotis T, Panagiotou P, Douros K, Schams A, Lettieri S, Papaevangelou V, Kanaka-Gantenbein C, Karakatsani A, Loukides S, Costabel U, Crestani B, Morgan C, Tazawa R, Bush A, Griese M, Manali ED. COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study. ERJ Open Res. 2023.01; 9 (1): 00199-2022.
  24. Ohkouchi S, Kanehira M, Saigusa D, Ono M, Tazawa R, Terunuma H, Hirano T, Numakura T, Notsuda H, Inoue C, Saito-Koyama R, Tabata M, Irokawa T, Ogawa H, Kurosawa H, Okada Y. Metabolic and Epigenetic Regulation of SMAD7 by STC1 Ameliorates Lung Fibrosis. Am J Respir Cell Mol Biol. 2022.09; 67 (3): 320-333.

原著論文(和文)

  1. 石山 裕之, 秀島 雅之, 犬飼 周佑, 玉岡 明洋, 西山 暁, 宮崎 泰成. 閉塞性睡眠時無呼吸における, 口腔内装置療法の効果予測因子としての呼吸抵抗の評価 予備研究 睡眠口腔医学. 2022.05; 8 (3): 64-72.
  2. 高澤 聖子, 白井 剛, 河原 達雄, 岡本 師, 立石 知也, 宮崎 泰成. 冬季に再燃した抗Trichosporon asahii抗体陽性の過敏性肺炎の1例 日本呼吸器学会誌. 2023.03; 12 (2): 69-73.
  3. 岡本 師, David A. Schwartz, 宮崎 泰成. Muc5bは過敏性肺炎マウスモデルにおいて重要な役割を果たしている 日本肺サーファクタント・界面医学会雑誌 2022.08; 53: 35-36.
  4. 惠島 将, 岡本 師, 島村 貴史, 鈴木 崇文, 宮崎 泰成. 線維性過敏性肺炎のステロイド治療における気管支肺胞洗浄液中のリンパ球分画と予後との関連 気管支学. 2022.07; 44 (4): 259-267.
  5. 高澤 聖子, 岡本 師, 細谷 龍作, 榊原 里江, 石塚 聖洋, 宮﨑 泰成. CEAが異常高値を呈した嚢胞を伴う濾胞性細気管支炎の1例 日呼吸誌. 2023.02; 12 (3): 154-159.
  6. 宮崎 泰成. 過敏性肺炎をめぐる最近の話題 診断 呼吸器内科医の役割 日本サルコイドーシス/肉芽腫性疾患学会雑誌. 2022.10; 42 (1-2): 47-55.
  7. 宮崎 泰成. 【間質性肺疾患:実地臨床における診療のポイント】過敏性肺炎における診療のポイント 日本内科学会雑誌. 2022.06; 111 (6): 1084-1091.

著書

  1. 岡本 師, 宮崎 泰成. 病歴が驚くほど診断の決め手になった症例 case4 内科. 2022.08; 5(130).
  2. 岡本 師, 宮崎 泰成. 急性呼吸不全と病態生理 入門新呼吸療法. 2023.03; 17-21.
  3. 日本呼吸器学会 過敏性肺炎診療指針2022 作成委員会. 過敏性肺炎診療指針2022. 2022.04.
  4. 日本呼吸器学会肺胞蛋白症診療ガイドライン2022作成委員会 (井上 義一, 赤坂 圭一, 審良 正則, 新井 徹, 石井 晴之, 一和多 俊男, 内田 寛治, 海老名 雅仁, 大河内 眞也, 木田 博, 北市 正則, 上甲 剛, 杉本 親寿, 鈴木 拓児, 鈴木 雅, 澄川 裕充, 瀬戸口 靖弘, 高田 俊範, 武村 民子, 田澤 立之, 田中 崇裕, 長和 俊, 富井 啓介, 中田 光, 中山 秀章, 広瀬 雅樹, 森本 浩之輔, 山口 悦郎, 吾妻 安良太, 稲瀬 直彦, 本間 栄, 近藤 康博, 萩原 弘一, 小林 剛志, 坂東 政司, 巽 浩一郎, 中山 健夫, 初田 和由). 肺胞蛋白症診療ガイドライン2022. 2022.06.

商業誌

  1. 宮崎 泰成. 【1ページでわかる内科疾患の診療ノート-"あたりまえ"のなかにある大事な視点】(第1章)呼吸器 急性・慢性(非線維性・線維性)過敏性肺炎 内科. 2022.04; 129 (4): 558-562.
  2. 宮崎 泰成. 【吸い込みでおこる肺疾患の画像診断と病理】過敏性肺炎ガイドライン 画像診断. 2022.08; 42 (10): 962-971.
  3. 宮崎 泰成. 治療法の再整理とアップデートのために 専門家による私の治療 過敏性肺炎 日本医事新報. 2022.08; (5131): 42-43.
  4. 宮崎 泰成. 【びまん性肺疾患-病態・臨床の最新知見-】総論 びまん性肺疾患の原因と分類 日本臨床. 2022.09; 80 (9): 1346-1350.
  5. 岡本 師. 線維性過敏性肺炎 呼吸器内科. 2022.12; 6(42).
  6. 岡本 師. 線維性過敏性肺炎 日本臨牀. 2022.09; 9 (80).
  7. 古澤 春彦. 【びまん性肺疾患-病態・臨床の最新知見-】診断と治療 膠原病関連肺疾患と類縁疾患 肺サルコイドーシス 日本臨床. 2022.09; 9 (80): 1461-1465.
  8. 古澤 春彦. 呼吸器内科専門医のための模擬テスト4 呼吸器内科. 2022.12; 6 (42): 683.
  9. 宮崎 泰成, 冨岡 洋海. 【間質性肺疾患の研究と診療UPDATE】過敏性肺炎 国際診断ガイドラインとわが国の診療指針 医学のあゆみ. 2022.10; 283 (1): 67-75.
  10. 宮崎 泰成. 治療法の再整理とアップデートのために 専門家による私の治療 サルコイドーシス 日本医事新報. 2022.10; (5138): 51.
  11. 小松崎 恵子, 宮崎 泰成. 【シン・アレルギー診療 プライマリ・ケア領域のアレルギーアップデート】「○○」とアレルギー 「仕事」とアレルギー 治療. 2022.10; 104 (10): 1235-1237.
  12. 岡本 師, 宮崎 泰成. 【好きになる呼吸器学-珠玉の症例集から】珠玉の症例集 印象深い症例・思い出の症例より [Case 11]職業・生活環境だけでなく,患者の趣味まで聴取する 内科. 2022.11; 130 (5): 907-910.
  13. 宮崎 泰成. 【肺炎の最近の動向-感染症から特殊な肺炎まで】過敏性肺炎 カレントテラピー. 2022.11; 40 (11): 1077-1082.
  14. 飯島 裕基, 宮崎 泰成. 【呼吸器診断マスター-病歴,身体所見,画像所見でここを見る!】呼吸器内科医がよく遭遇するコンサルト案件 職業関連肺疾患 呼吸器ジャーナル. 2022.11; 70 (4): 581-589.
  15. 白井 剛, 宮崎 泰成. びまん性肺疾患診療におけるイムノキャップ特異的IgG鳥の活用法 呼吸器内科. 2023.03; 3 (43): 280-286.
  16. 立石 知也. 【びまん性肺疾患-病態・臨床の最新知見-】診断と治療 過敏性肺炎 線維性過敏性肺炎 日本臨牀. 2022.09; 9 (80): 1432-1441.
  17. 立石 知也. 【耳鼻咽喉科領域におけるコロナ後遺症-どう診る,どう治す-】COVID-19後遺症としての呼吸器障害 ENTONI. 2022.12; 278: 43-48.
  18. 立石 知也. 間質性肺炎のフェノタイプ研究 呼吸器内科. 2022.12; 6(42): 667-671.
  19. 田澤 立之. 【呼吸器難病の課題と展望】肺胞蛋白症(自己免疫性又は先天性)(解説) 呼吸器内科. 2022.11; 42 (5): 505-511.
  20. 田中 崇裕, 田澤 立之. 【呼吸器難病の課題と展望】肺胞蛋白症(自己免疫性又は先天性)(解説) 呼吸器内科. 2022.5; 41 (5): 483-487.

2021年業績

山名 高志

原著論文(英文)

  1. Shirai T, Tanino Y, Nikaido T, Takaku Y, Hashimoto S, Taguchi Y, Baba T, Ogura T, Kataoka K, Nakayama M, Yamada Y, Matsushima S, Nakayama S, Miyazaki Y. Screening and diagnosis of acute and chronic bird-related hypersensitivity pneumonitis by serum IgG and IgA antibodies to bird antigens with ImmunoCAP®. Allergol Int. 2021 Apr;70(2):208-214.
  2. Okazaki T, Yokoyama K, Tsuchiya J, Honda T, Ishikawa Y, Kirimura S, et al. SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT. Eur J Hybrid Imaging. 2021 Apr 27;5(1):8
  3. Murakami N, Asami Y, Yoshida H, Takayanagi D, Hirose S, Kuno I, et al. Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy. Sci Rep 11, 10567 (2021).
  4. Tasaka Y, Honda T, Nishiyama N, Tsutsui T, Saito H, Watabe H, et al. Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung disease. May;155:120-126.
  5. Mitsumura T, Okamoto T, Shirai T, Iijima Y, Sakakibara R, Honda T, Ishizuka M, Aiboshi J, Tateishi T, Tamaoka M, Shigemitsu H, Arai H, Otomo Y, Tohda S, Anzai T, Takahashi K, Yasuda S, Miyazaki Y. Predictors associated with clinical improvement of SARS-CoV-2 pneumonia. J Infect Chemother. 2021 Jun;27(6):857-863.
  6. Maruyama H, Taguchi A, Mikame M, Izawa A, Morito N, Izaki K, Seto T, Onishi A, Sugiyama H, Sakai N, Yamabe K, Yokoyama Y, Yamashita S, Satoh H, Toyoda S, Hosojima M, Ito Y, Tazawa R, Ishii S. Plasma Globotriaosylsphingosine and α-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese Cohort. Curr Issues Mol Biol. 2021 Jun 19;43(1):389-404.
  7. Ejima M, Okamoto T, Suzuki T, Anzai T, Takahashi K, Miyazaki Y. Efficacy of treatment with corticosteroids for fibrotic hypersensitivity pneumonitis: a propensity score-matched cohort analysis. BMC Pulm Med. 2021 Jul 19;21(1):243.
  8. Niemi MEK, Karjalainen J, Liao RG, Neale BM, Daly M, Ganna A, et al. Mapping the human genetic architecture of COVID-19. Nature. 2021 Dec;600(7889):472-477. Epub 2021 Jul 8.
  9. Majima H, Arai T, Kusuya Y, Takahashi H, Watanabe A, Miyazaki Y, Kamei K. Genetic differences between Japan and other countries in cyp51A polymorphisms of Aspergillus fumigatus. Mycoses. 2021 Nov;64(11):1354-1365. Epub 2021 Sep 29.
  10. Mitsumura T, Kumaki Y, Takahashi K, Matsudera S, Sakakibara R, Honda T, Ishizuka M, Iijima Y, Shirai T, Okamoto T, Tateishi T, Sakashita H, Miyake S, Ikeda S, Miyazaki Y. Treatment of advanced lung cancer based on genomic profiling using liquid biopsy (plasma): A review of three cases. Thorac Cancer. 2021 Sep;12(18):2508-2512.
  11. Shimada S, Nakai R, Aoki K, Kudoh S, Imura S, Shimoeda N, Ohno G, Watanabe K, Miyazaki Y, Ishii Y, Tateda K. Characterization of the First Cultured Psychrotolerant Representative of Legionella from Antarctica Reveals Its Unique Genome Structure. Microbiol Spectr. 2021 Oct 31;9(2):e0042421.
  12. Uchida K, Furukawa A, Yoneyama A, Furusawa H, Kobayashi D, Ito T, Yamamoto K, Sekine M, Miura K, Akashi T, Eishi Y, Ohashi K. Propionibacterium acnes-Derived Circulating Immune Complexes in Sarcoidosis Patients. Microorganisms. 2021 Oct 21;9(11):2194.
  13. Sugihara J, Shibata S, Doi M, Shimmura T, Inoue S, Matsumoto O, Suzuki H, Makino A, Miyazaki Y. Atypical lymphocytes in the peripheral blood of COVID-19 patients: A prognostic factor for the clinical course of COVID-19. PLoS One. 2021 Nov 12;16(11)
  14. Karasuyama H, Shibata S, Yoshikawa S, Miyake K. Basophils, a neglected minority in the immune system, have come into the limelight at last. Int Immunol. 2021 Nov 25;33(12):809-813.
  15. Oba S, Hosoya T, Amamiya M, Mitsumura T, Kawata D, Sasaki H, Kamiya M, Yamamoto A, Ando T, Shimada S, Shirai T, Okamoto T, Tateishi T, Endo A, Aiboshi J, Nosaka N, Yamanouchi H, Ugawa T, Nagaoka E, Oi K, Tao S, Maejima Y, Tanaka Y, Tanimoto K, Takeuchi H, Tohda S, Hirakawa A, Sasano T, Arai H, Otomo Y, Miyazaki Y, Yasuda S. Arterial and Venous Thrombosis Complicated in COVID-19: A Retrospective Single Center Analysis in Japan. Front Cardiovasc Med. 2021 Nov 19;8:767074.
  16. Matsudera S, Kano Y, Aoyagi Y, Tohyama K, Takahashi K, Kumaki Y, Mitsumura T, Kimura K, Onishi I, Takemoto A, Ban D, Ono H, Kudo A, Oshima N, Ogino K, Watanabe S, Tani Y, Yamaguchi T, Nakajima M, Morita S, Yamaguchi S, Takagi M, Ishikawa T, Nakagawa T, Okamoto K, Uetake H, Tanabe M, Miyake S, Tsuchioka T, Kojima K, Ikeda S. A Pilot Study Analyzing the Clinical Utility of Comprehensive Genomic Profiling Using Plasma Cell-Free DNA for Solid Tumor Patients in Japan (PROFILE Study). Ann Surg Oncol. 2021 Dec;28(13):8497-8505.
  17. Sagawa R, Sakata S, Gong B, Seto Y, Takemoto A, Takagi S, Ninomiya H, Yanagitani N, Nakao M, Mun M, Uchibori K, Nishio M, Miyazaki Y, Shiraishi Y, Ogawa S, Kataoka K, Fujita N, Takeuchi K, Katayama R. Soluble PD-L1 works as a decoy in lung cancer immunotherapy via alternative polyadenylation. JCI Insight. 2022 Jan 11;7(1):e153323.
  18. Furusawa H, Peljto AL, Walts AD, Cardwell J, Molyneaux PL, Lee JS, Fernández Pérez ER, Wolters PJ, Yang IV, Schwartz DA. Common idiopathic pulmonary fibrosis risk variants are associated with hypersensitivity pneumonitis. Thorax. 2022 May;77(5):508-510. Epub 2022 Jan 7.
  19. Murakami T, Iijima Y, Ando T, Ejima M, Shirai T, Furusawa H, Okamoto T, Tateishi T, Tamaoka M, Miyazaki Y. Successful diagnosis of humidifier lung by individual provocation test to a responsible environment, a case report. Respir Med Case Rep. 2022 Mar
  20. Ejima M, Okamoto T, Suzuki T, Miyazaki Y. Role of serum surfactant protein-D as a prognostic predictor in fibrotic hypersensitivity pneumonitis. Respir Investig. 2022 May;60(3):369-378.
  21. Tomomasa D, Tanita K, Higashi S, Tasaka Y, Shimamura T, Sakurai U, Matsubara T, Okada S, Morio T, Kanegane H. Early diagnosis of partial interferon-γ receptor 1 deficiency prevents the development of Bacille de Calmette et Guérin osteomyelitis. Clin Immunol. 2022 Feb;235:108933.
  22. Katayanagi S, Setoguchi Y, Kitagawa S, Okamoto T, Miyazaki Y. Alternative Gene Expression by TOLLIP Variant Is Associated With Lung Function in Chronic Hypersensitivity Pneumonitis. Chest. 2022 Feb;161(2):458-469.
  23. Aoyagi Y, Kano Y, Tohyama K, Matsudera S, Kumaki Y, Takahashi K, Mitsumura T, Harada Y, Sato A, Nakamura H, Sueoka E, Aragane N, Kimura K, Onishi I, Takemoto A, Akahoshi K, Ono H, Ishikawa T, Tokunaga M, Nakagawa T, Oshima N, Nakamura R, Takagi M, Asakage T, Uetake H, Tanabe M, Miyake S, Kinugasa Y, Ikeda S. Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study. PLoS One. 2022 Mar 31;17(3):e0266112. doi: 10.1371/journal.pone.0266112.
  24. Endo S, Honda T, Kawahara T, Sakakibara R, Mitsumura T, Okamoto T, Miyazaki Y. Profile of metastatic lung cancer patients susceptible to development of thromboembolism during immunotherapy. Cancer Treat Res Commun. 2022;31:100547. doi: 10.1016/j.ctarc.2022.100547. Epub 2022 Mar 10.

原著論文(和文)

  1. 遠藤 駿, 北野正剛, 丸田竜介, 雨宮光男, 松本崇平, 西山直樹, 小林正芳. 非小細胞肺癌治療中に発症したnon-O1, non-O139 Vibrio cholerae菌血症の1例. 感染症学雑誌95巻3号 p. 314-318
  2. 山下将平, 三ツ村隆弘, 鈴木崇文, 榊原里江, 本多隆行, 宮崎泰成. 薬剤性肺障害を反復するも異なる免疫チェックポイント阻害薬を継続投与し得た肺腺癌の1例肺癌(0386-9628)61巻3号 Page201-207(2021.06)
  3. 丸山総一,鈴木崇文,高梨靖久,近藤大地,千秋智重. ペムブロリズマブを含むプラチナ併用化学療法が有効であった肺多形癌の2例. 日本呼吸器学会誌(2186-5876)10巻5号 Page415-420(2021.09)
  4. 安東敬大,清水郷子,杉浦真貴子,藤江俊秀. 日呼吸誌, 10(5): 421-426, 2021
  5. 片柳真司,岡本 師,瀬戸口靖弘,宮崎泰成. 本邦の慢性過敏性肺炎におけるMUC5Bプロモーター多型の特徴と拘束性障害の進展の検討. 日本肺サーファクタント・界面医学会雑誌(1882-1812)52巻 Page36-37(2021.10)
  6. 田澤立之. 肺胞蛋白症とGM-CSF吸入治療. 日本内科学会雑誌(0021-5384)110巻9号 Page1918-1925(2021.09)
  7. 榊原里江, 本多隆行, 三ツ村隆弘, 桐村 進, 大久保憲一, 宮崎泰成. オンコマイン™ Dx Target TestⓇの検査成功に関連する因子の探索. 肺癌2021年61巻7号 p.932-938

著書

  1. 宮崎泰成. 過敏性肺炎 原因抗原の特定 アレルギー(0021-4884)71巻1号Page58
  2. 宮崎泰成. 【呼吸器症候群(第3版)-その他の呼吸器疾患を含めて-】びまん性肺疾患 肉芽腫性肺疾患 肉芽腫性間質性肺炎. 日本臨床(0047-1852)別冊呼吸器症候群III Page123-126(2021.10)
  3. 岡本師. 類上皮細胞肉芽腫 日本臨床増刊 呼吸器症候群(第3版)III 2021年11月
  4. 田澤立之. 肺胞蛋白症. 今日の治療指針2022(総編集 福井次矢 高木誠 小室一成)(2022年1月)

商業誌

  1. 柴田 翔, 烏山 一. 先端医学講座 慢性閉塞性肺疾患の病態における好塩基球、間質マクロファージの役割アレルギーの臨床(0285-6379)41巻6号 Page494-497(2021.06)
  2. 遠藤 駿. 過敏性肺炎動物モデル 呼吸器内科(1884-2887)40巻2号 Page206-210(2020年8月)
  3. 山名高志. 「話題」メモリーγδT細胞 呼吸器内科(1884-2887)第40巻2号 Page 176-181
  4. 惠島将. 特集 過敏性肺炎ガイドラインを読み解く 9. 抗原問診票 呼吸器内科 (1884-2887) 第40巻2号 Page 150-158
  5. 白井剛. 鳥関連過敏性肺炎の原因抗原 吸器内科 (1884-2887) 第40巻2号 Page 195-200
  6. 古澤春彦. 宮崎泰成慢性過敏性肺炎の遺伝子発現解析 呼吸器内科(1884-2887)第40巻2号
  7. 立石知也. 【過敏性肺炎ガイドラインを読み解く】ガイドラインを参考にした治療. 呼吸器内科(1884-2887)第40巻2号
  8. 岡本師. CHESTガイドライン2021~ATS/JRS/ALATガイドラインとの比較. 吸器内科(1884-2887)第40巻2号
  9. 立石知也,惠島将,宮﨑泰成. 慢性過敏性肺炎の診断と治療 呼吸器ジャーナル. 69巻3号(2021年8月)
  10. 柴田 翔. 慢性閉塞性肺疾患の病態における好塩基球の役割. 呼吸器内科(1884-2887)第40巻6号
  11. 山名高志. 肺疾患と粘膜免疫. 呼吸器内科(1884-2887)第40巻6号Page 563-567
  12. 田澤立之. 肺胞マクロファージ(1884-2887)第40巻6号Page626-631
  13. 白井 剛, 宮崎泰成. 臨床検査アップデート 鳥特異的IgG抗体 過敏性肺炎診断におけるイムノキャップ特異的IgG鳥測定の意義 Modern Media 2021.12/12 67巻 p501-505
  14. 白井 剛, 鳥羽三佳代, 工藤 篤. 【医療安全をとおしてガバナンスを考える】東京医科歯科大学医学部附属病院(東京都文京区)当院の死亡事例検証システムの運用実態とその有用性・課題. 患者安全推進ジャーナル. 2021.12. 66巻 23-27
  15. 島田翔. 南極の低温環境に棲むLegionella属菌. ビルと環境, 2021年12月, 175巻p35-39
  16. 田澤立之. 肺胞蛋白症ーある稀少肺疾患の小さな物語. 難病と在宅ケア(ISSN 1880-9200)2021年12月, 9号27巻p24-28
  17. 白井 剛. イムノキャップ特異的IgG鳥. 呼吸器内科(1884-2887) 2022.2 第41巻2号p202-205

2020年業績

原著

  1. Tazawa R, Kitamura N, Nakata K. Inhaled GM-CSF for Pulmonary Alveolar Proteinosis. Reply. N Engl J Med. 2020 Jan 9;382(2):198.
  2. Sakakibara R, Kobayashi M, Takahashi N, Inamura K, Ninomiya H, Wakejima R, Kitazono S, Yanagitani N, Horiike A, Ichinose J, Matsuura Y, Nakao M, Mun M, Nishio M, Okumura S, Motoi N, Ito T, Miyazaki Y, Inase N, Ishikawa Y. Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56. Am J Surg Pathol. 2020;44(6):757-764
  3. Kunimasa K, Hirotsu Y, Nakamura H, Tamiya M, Iijima Y, Ishida H, Hamamoto Y, Maniwa T, Kimura T, Nishino K, Goto T, Amemiya K, Mochizuki H, Oyama T, Nakatsuka S, Kumagai T, Okami J, Higashiyama M, Imamura F, Omata M. Rapid Progressive Lung Cancers Harbouring Multiple Clonal Driver Mutations With Big Bang Evolution Model. Cancer Genet. 2020; 241:51-56
  4. Iijima Y, Tateishi T, Tsuchiya K, Sumi Y, Akashi T, Miyazaki Y. Pneumoconiosis Caused by Inhalation of Metallic Titanium Grindings. Intern Med. 2020;59(3):425-428
  5. Hirose S, Murakami N, Takahashi K, Kuno I, Takayanagi D, Asami Y, Matsuda M, Shimada Y, Yamano S, Sunami K, Yoshida K, Honda T, Nakahara T, Watanabe T, Komatsu M, Hamamoto R, Kobayashi Kato M, Matsumoto K, Okuma K, Kuroda T, Okamoto A, Itami J, Kohno T, Kato T, Shiraishi K, Yoshida H. Genomic Alterations in STK11 Can Predict Clinical Outcomes in Cervical Cancer Patients. Gynecol Oncol. 2020;156(1):203-210
  6. Nishiyama N, Honda T, Sema M, Kawahara T, Jin Y, Natsume I, Chiaki T, Yamashita T, Tsukada Y, Taki R, Miyashita Y, Saito K, Tateishi T, Sakashita H, Miyazaki Y. The Utility of Ground-Glass Attenuation Score for Anticancer Treatment-Related Acute Exacerbation of Interstitial Lung Disease Among Lung Cancer Patients With Interstitial Lung Disease. Int J Clin Oncol. 2020;25(2):282-291
  7. Wong JYY, Zhang H, Hsiung CA, Shiraishi K, Yu K, Matsuo K, Honda T, Kohno T, Qing Lan, et al. Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women. Genomics 2020;112(2):1223-1232
  8. Tateishi T, Johkoh T, Sakai F, Miyazaki Y, Ogura T, Ichikado K, Suda T, Taguchi Y, Inoue Y, Takemura T, Colby TV, Sumikawa H, Fujimoto K, Arakawa H, Raoof S, Inase N. High-resolution CT features distinguishing usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis from those with idiopathic pulmonary fibrosis. Jpn J Radiol. 2020;38(6):524-532
  9. Iijima Y, Sakakibara R, Ishizuka M, Honda T, Shirai T, Okamoto T, Tateishi T, Sakashita H, Tamaoka,M, Takemoto A, Kumaki Y, Ikeda S, Miyazaki Y. Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report.Immunotherapy. 2020.01; 12(8); 563-569
  10. Hayashi S, Tamaoka M, Tateishi T, Murota Y, Handa I, Miyazaki Y. A New Feature with the Potential to Detect the Severity of Obstructive Sleep Apnoea via Snoring Sound Analysis. International Journal of Environmental Research and Public Health. 2020.04; 17(8); 2951
  11. Shimada S, Nakai R, Aoki K, Shimoeda N, Ohno G, Miyazaki Y, Kudoh S, Imura S, Watanabe K, Ishii Y,Tateda K. Complete Genome Sequence of Novel Psychrotolerant Legionella Strain TUM19329, Isolated from Antarctic Lake Sediment. Microbiology Resource Announcements. 2020.04; 9(16); e00253-20
  12. Hanzawa S, Tateishi T, Ishizuka M, Inoue Y, Honda T, Kawahara T, Tomita M, Miyazaki Y. Changes in serum KL-6 levels during short-term strict antigen avoidance are associated with the prognosis of patients with fibrotic hypersensitivity pneumonitis caused by avian antigens. Respiratory Investigation. 2020.07;S2212-5345(20); 30092-7
  13. Watanabe T, Honda T, Totsuka H, Yoshida M, Tanioka M, Shiraishi K, Shimada Y, Arai E, Ushiama, M, Tamura K, Yoshida T, Kanai Y, Kohno T. Simple prediction model for homologous recombination deficiency in breast cancers in adolescents and young adults. Breast Cancer Research and Treatment.2020.07; 182(2); 491-502
  14. Tanioka M, Watanabe T, Honda T, Totsuka H, Arai , Kanai Y, Shiraishi K, Tamura K, Kohno T. Simple vs. comprehensive prediction models of homologous recombination deficiency based on mutational and clinical features in three independent breast cancer datasets. Cancer Research. 2020.08; 80(16); 3551
  15. Shirai T, Mitsumura T, Aoyagi K, Okamoto T, Kimura M, Gemma T, Shigematsu T, Takahashi J, Azuma, S, Yoshizuka R, Sasaki H, Urushibata N, Ochiai K, Hondo K, Morishita K, Aiboshi J, Otomo Y, MiyazakiY. COVID-19 pneumonia complicated by bilateral pneumothorax: A case report. Respiratory Medicine Case Reports. 2020.09; 31; 101230
  16. Nishiyama N, Masuo M, Nukui Y, Tateishi T, Kishino M, Tateishi U, Morota K, Ohbo K, Miyazaki Y.Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease. Respiratory Investigation. 2020.09; 59(1); 90-98
  17. Inoue Y, Okamoto T, Honda T, Nukui Y, Akashi T, Takemura T, Tozuka M, Miyazaki Y. Disruption in the balance between apolipoprotein A-I and mast cell chymase in chronic hypersensitivity pneumonitis.Immunity Inflammation and Disease. 2020.10; 8(4); 659-671
  18. Shirai T, Tanino Y, Nikaido T, Takaku Y, Hashimoto S, Taguchi Y, Baba T, Ogura T, Kataoka K,Nakayama M, Yamada Y, Matsushima S, Nakayama S, Miyazaki Y. Screening and diagnosis of acute and chronic bird-related hypersensitivity pneumonitis by serum IgG and IgA antibodies to bird antigens with ImmunoCAP®. Allergology International. 2020.10; S1323-8930(20); 30128-3
  19. Furusawa H, Cardwell JH, Okamoto T, Walts AD, Konigsberg IR, Kurche JS, Bang TJ, Schwarz MI,Brown KK, Kropski JA, Rojas M, Cool CD, Lee JS, Wolters PJ, Yang IV, Schwartz DA. Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures. American Journal of Respiratory and Critical Care Medicine. 2020.11; 202(10); 1430-1444
  20. Johannson KA, Barnes H, Bellanger AP, Dalphin JC, Fern´andez P´erez ER, Flaherty KR, Huang YT, Jones KD, Kawano-Dourado L, Kennedy K, Millerick-May M, Miyazaki Y, Morisset J, Morell F, Raghu GR,Robbins C, Sack CS, Salisbury ML, Selman M, Vasakova M, Walsh SLF, Rose CS. Exposure Assessment Tools for Hypersensitivity Pneumonitis. An Official American Thoracic Society Workshop Report. Annals of the American Thoracic Society. 2020.12; 17(12); 1501-1509
  21. Yamana T, Okamoto T, Ishizuka M, Hanzawa S, Ejima M, Shibata S, Miyazaki Y. IL-17A-Secreting Memory γδ T Cells Play a Pivotal Role in Sensitization and Development of Hypersensitivity Pneumonitis. Journal of Immunology. 2020.12; 206(2); 355-356
  22. Okamoto Y, Ghosh T, Okamoto T, Schuyler RP, Seifert J, Charry LL, Visser A, Feser M, Fleischer C,Pedrick C, August J, Moss L, Bemis EA, Norris JM, Kuhn KA, Demoruelle MK, Deane KD, Ghosh D,Holers VM, Hsieh EWY. Subjects at-risk for future development of rheumatoid arthritis demonstrate a PAD4-and TLR-dependent enhanced histone H3 citrullination and proinflammatory cytokine production in CD14hi monocytes. Journal of Autoimmunity. 2020.12; 117; 102581
  23. Gally F, Sasse SK, Kurche J, Gruca MA, Cardwell JH, Okamoto T, Chu HW, Hou X, Poirion O, Buchanan J, Preissl S, Ren B, Colgan SP, Dowell RD, Yang IV, Schwartz DA, Gerber AN. The MUC5B-associated variant, rs35705950, resides within an enhancer subject to lineage- and disease-dependent epigenetic remodeling. JCI Insight. 2020.12; 6(2); e144294
  24. 馬嶋秀考,原哲,今瀬玲菜,神靖人,松原修,宮崎泰成. 肺癌との鑑別を要し免疫学的診断法が有用であった肺吸虫症の1例. 日本呼吸器学会誌 2020; 9(1): 38-42
  25. 安東敬大, 西山直樹, 本多隆行, 桐村進, 榊原里江, 三ツ村隆弘, 遠山皓基, 加納嘉人, 池田貞勝, 宮崎泰成. 遺伝子パネル検査を組み合わせることで、確定診断と適正な治療選択が可能となった、上顎洞癌の胸膜転移の1 例.肺癌. 2020.08; 60(4); 364-370

総説

  1. Costabel U, Miyazaki Y, Pardo A, Koschel D, Bonella F, Spagnolo P, Guzman J, Ryerson CJ, Selman M.Hypersensitivity pneumonitis. Nature Reviews Disease Primers. 2020.08; 6(1); 65
  2. 榊原里江. PD-L1蛋白免疫染色(免疫抗体法). 内科 2020;125:1054-1055
  3. 岡本師. 【喘息とCOPD】知っておいてほしいサブタイプと肺の併存疾患 気腫合併肺線維症(CPFE) 内科. 2020.06; 125(6); 1385-1388
  4. 岡本師, 早稲田優子. 過敏性肺炎の診断について 曝露歴、HRCT 所見、BAL 所見、免疫学的検査が重要 日本医事新報. 2020.10; (5035); 41-42
  5. 立石知也, 宮崎泰成. 【肺炎-抗菌薬だけではすまされない肺炎診療の落とし穴】最新の実地診療のポイント整理と活用 急性過敏性肺炎Medical Practice. 2020.10; 37(10); 1567-1570

2019年業績

原著

  1. Shibata S, Furusawa H, Inase N. Pirfenidone in chronic hypersensitivity pneumonitis: a real-life experience. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES. 2019;35(2):139-42.
  2. Hanzawa S, Tateishi T, Takemura T, Okada Y, Yamada Y, Noda M, et al. The Analysis of Surgical Lung Biopsy and Explanted Lung Specimens Sheds Light on the Pathological Progression of Chronic Bird-related Hypersensitivity Pneumonitis. Internal medicine 2019;58:1145-50.
  3. Nagashima R, Kosai H, Masuo M, Izumiyama K, Noshikawaji T, Morimoto M, et al. Nrf2 Suppresses Allergic Lung Inflammation by Attenuating the Type 2 Innate Lymphoid Cell Response. Journal of immunology 2019;202:1331-9.
  4. Inoue Y, Ishizuka M, Furusawa H, Honda T, Kawahara T, Tateishi T, et al. Acute inflammatory and immunologic responses against antigen in chronic bird-related hypersensitivity pneumonitis. Allergology international 2019;68(3):321-8.
  5. Saiki M, Iijima Y, Honda T, Mori S, Tsutsui T, Uchida Y, et al. Coexistence of dementia with smear-positive pulmonary tuberculosis is associated with patient in-hospital mortality. Respiratory Investigation 2019;57(4):354-60.
  6. Nukui Y, Miyazaki Y, Masuo M, Okamoto T, Furusawa H, Tateishi T, et al. Periostin as a predictor of prognosis in chronic bird-related hypersensitivity pneumonitis. Allergology international 2019;68(3):368-9.
  7. Saito H, Sakakibara Y, Sakata A, Kurashige R, Murakami D, Kageshima H, Saito A, Miyazaki Y. Antibacterial activity of lysozyme-chitosan oligosaccharide conjugates (LYZOX) against Pseudomonas aeruginosa, Acinetobacter baumannii and Methicillin-resistant Staphylococcus
  8. aureus. PLoS One. 2019 28;14(5):e0217504
  9. Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, Bishop M, Russell P, Okamoto T, Furusawa H, Miyazaki Y, Nickerson DA, Fingerlin TE, Schwartz DA, et al. Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis. 2019; 15;200(2):199-208.
  10. Tao M, Liu Q, Miyazaki Y, Canning BJ. Nicotinic receptor dependent regulation of cough and other airway defensive reflexes. Pulm Pharmacol Ther. 2019; 58:101810
  11. Nei T, Urano S, Motoi N, Hashimoto A, Kitamura N, Tanaka T, Nakagaki K, Takizawa J, Kaneko C, Tazawa R, Nakata K. Memory B cell pool of autoimmune pulmonary alveolar proteinosis patients contains higher frequency of GM-CSF autoreactive B cells than healthy subjects. Immunol Lett. 2019 Aug;212:22-29.
  12. Tazawa R, Ueda T, Abe M, Tatsumi K, Eda R, Kondoh S, Morimoto K, Tanaka T, Yamaguchi E, Takahashi A, Oda M, Ishii H, Izumi S, Sugiyama H, Nakagawa A, Tomii K, Suzuki M, Konno S, Ohkouchi S, Tode N, Handa T, Hirai T, Inoue Y, Arai T, Asakawa K, Sakagami T, Hashimoto A, Tanaka T, Takada T, Mikami A, Kitamura N, Nakata K. Inhaled GM-CSF for Pulmonary Alveolar Proteinosis. N Engl J Med. 2019 Sep 5;381(10):923-932.
  13. Uchida Y, Nakagome K, Tazawa R, Akasaka K, Ito M, Haga Y, Komiyama KI, Soma T, Nakata K, Nagata M. Modified eosinophil adhesion in pulmonary alveolar proteinosis caused by CSF2RA deletion. Allergol Int. 2019 Sep;68S:S14-S16.
  14. Kurche JS, Dobrinskikh E, Hennessy CE, Huber J, Estrella A, Hancock LA, Schwarz MI, Okamoto T, Cool CD, Yang IV, Evans CM, Schwartz DA. Muc5b Enhances Murine Honeycomb-like Cyst Formation. Am J Respir Cell Mol Biol. 2019; 61(4):544-546
  15. Kataoka K, Oda K, Takizawa H, Ogura T, Miyamoto A, Sekiguchi M, Akagawa S, Hashimoto S, Kishaba T, Hasegawa Y, Hamada N, Kuwano K, Nakayama M, Ebina M, Enomoto N, Miyazaki Y, Atsumi K, Izumi S, Tanino Y, Ishii H, Ohnishi H, Kondoh Y. Multi-institutional prospective cohort study of prognostic factors in patients with idiopathic pulmonary fibrosis receiving long-term oxygen therapy. European Respiratory Journal 2019;54:PA1723.
  16. Nakajima K, Ono M, Radović U, Dizdarević S, Tomizawa SI, Kuroha K, Naganatsu G, Hoshi I, Matsunaga R, Shirakawa T, Kurosawa T, Miyazaki Y, Seki M, Suzuki Y, Koseki H, Nakamura M, Suda T, Ohbo K. Lack of whey acidic protein four disulphide core (WFDC) 2 protease inhibitor causes neonatal death from respiratory failure in mice. Dis Model Mech. 2019; 12;12(11):dmm040139
  17. Kawahara T, Sakashita H, Suzuki T, Tateishi T, Miyazaki Y. Real world data of combined lung cancer and interstitial lung disease. J Thorac Dis. 2019;11(10):4144-4151
  18. Iijima Y, Hirotsu Y, Amemiya K, Higuchi R, Nakagomi T, Goto T, Uchida Y, Kobayashi Y, Tsutsui T, Kakizaki Y, Miyashita Y, Omata M. Endotracheal or Endobronchial Metastasis of Lung Squamous Cell Carcinoma. J Bronchology Interv Pulmonol. 2019;26(4):e46-e50
  19. Takezaki A, Tsukumo SI, Setoguchi Y, Ledford JG, Goto H, Hosomichi K, Uehara H, Nishioka Y, Yasutomo K. A homozygous SFTPA1 mutation drives necroptosis of type II alveolar epithelial cells in patients with idiopathic pulmonary fibrosis. J Exp Med. 2019; 216:2724-2735
  20. 鈴木 崇文, 古澤 春彦, 渡邉 雄大, 坂下 博之, 藤井 伸哉, 田坂 有理, 島田 翔, 馬嶋 秀考, 河原 達雄, 片柳 真司, 惠島 将, 貫井 義久, 白井 剛, 増尾 昌宏, 立石 知也, 藤江 俊秀, 玉岡 明洋, 田口 登和子, 冨井 翔平, 宮崎 泰成:ヒラメ筋転移をきたした腸型肺腺癌と考えられた1例.癌と化学療法 46(2):267-70, 2019.

著書

  1. 片柳真司 瀬戸口靖弘「慢性呼吸不全に対する栄養療法」南江堂 呼吸器疾患最新の治療
  2. 宮崎泰成 日本呼吸器内視鏡学会編 過敏性肺炎 サルコイドーシス Langerhans細胞組織球症 リンパ脈管筋腫症 気管支鏡テキスト第3版 2019
  3. 宮崎泰成 「大気環境関連疾患の予防と対策の手引き」(日本呼吸器学会大気環境関連疾患の予防と対策の手引き作成委員会 編集) メディカルレビュー社 2019:120-123.
  4. 片柳慎司、瀬戸口靖弘. 慢性呼吸不全に対する栄養療法. 呼吸器疾患の最新の治療2019-2020
  5. 瀬戸口靖弘. 胸部疾患. 第113回医師国家試験問題解説
  6. 瀬戸口靖弘 (分担執筆). 呼吸器. QUESTION BANK2020
  7. 瀬戸口靖弘 (分担執筆). サルコイドーシス. 新臨床内科学第10版

総説

  1. 立石知也. 【診療力を上げる! 症例問題集】(第1章)呼吸器 症例問題 繰り返す感冒様症状と労作時の息切れを主訴に受診した症例. 内科 (0022-1961)123巻4号 Page509-510
  2. 玉岡明洋. 肥満と睡眠時無呼吸. 呼吸器内科 (1884-2887)35巻4号 Page355-359
  3. 仁多寅彦, 稲瀬直彦, 三ツ村隆弘, 榊原里江. 座談会 呼吸器診療における標準治療の実践. 内科 2019;124:1499-1505
  4. 惠島将 宮崎泰成 特集 肉芽腫形成と呼吸器疾患:診断と治療の最前線 原因不明の肉芽腫症 2)過敏性肺炎(夏型過敏性肺炎を中心に) 呼吸器内科 2019:114-123.
  5. 宮崎泰成 特集 今日の呼吸器診療と今後の展望 Overreview:呼吸器のcommon disease びまん性肺疾患 内科 2019;124:1395-1400
  6. 宮崎泰成 特集 読むと得する!アレルギー診療の重要トリビア 15.羽毛布団や鳥の剥製で起こるアレルギー肺炎とは? Modern Physician 2019;39:758-761.
  7. 宮崎泰成 特集 特発性間質性肺炎:臨床診断の現状と課題 IPF/UIPと鑑別を要する疾患:慢性過敏性肺炎 呼吸器内科 2019;36:324-329
  8. 宮崎泰成 特集 びまん性肺疾患診療の新しい展開 肉芽腫性肺疾患 過敏性肺炎 臨床と研究 2019;96:51-56
  9. 本多隆行, 宮崎泰成, 河野隆志. 間質性肺炎合併肺がんの発症機構. 肺癌 2019;59:1134-9.

2018年業績

原著

  1. Nukui Y, Miyazaki Y, Suhara K, Okamoto T, Furusawa H, Inase N. Identification of apolipoprotein A-I in BALF as a biomarker of sarcoidosis Sarcoidosis Vasculitis and Diffuse Lung Diseases. 2018; 35; 5-15
  2. Kusaka Y, Kajiwara C, Shimada S, Ishii Y, Miyazaki Y, Inase N, Standiford TJ, Tateda K. Potential Role of Gr-1+ CD8+ T Lymphocytes as a Source of Interferon-γ and M1/M2 Polarization during the Acute Phase of Murine Legionella pneumophila Pneumonia. 2018;10:328-38.
  3. Sonoda S, Yamaguchi T, Aoki K, Ono D, Sato A, Kajiwara C, et al. Evidence of latent molecular diversity determining the virulence of community-associated MRSA USA300 clones in mice. Immunity, inflammation and disease 2018;6:402-12.
  4. Honda T, Sakashita H, Masai K, Totsuka H, Motoi N, Kobayashi M, et al. Deleterious Pulmonary Surfactant System Gene Mutations in Lung Adenocarcinomas Associated With Usual Interstitial Pneumonia. JCO Precision Oncology 2018:1-24.
  5. Okamoto T, Mathai SK, Hennessy CE, Hancock LA, Walts AD, Stefanski AL, et al. The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis. American journal of physiology Lung cellular and molecular physiology 2018;315:L1-l10.
  6. Shibata S, Miyake K, Tateishi T, Yoshikawa S, Yamanishi Y, Miyazaki Y, et al. Basophils trigger emphysema development in a murine model of COPD through IL-4-mediated generation of MMP-12-producing macrophages. Proceedings of the National Academy of Sciences of the United States of America 2018;115:13057-62.
  7. Mitsumura T, Ito Y, Chiba T, Matsushima T, Kurimoto R, Tanaka Y, et al. Ablation of miR-146b in mice causes hematopoietic malignancy. Blood advances 2018;2:3483-91.
  8. Kolb M, Bondue B, Pesci A, Miyazaki Y, Song JW, Bhatt NY, et al. Acute exacerbations of progressive-fibrosing interstitial lung diseases. European respiratory review : an official journal of the European Respiratory Society 2018;27.
  9. 鈴木 崇文, 立石 知也, 坂下 博之, 河原 達雄, 瀬間 学, 島田 翔, 渡邉 雄大, 明石 巧, 稲瀬 直彦, 宮崎 泰成:急性増悪時に環境中鳥抗原量の上昇を伴った慢性鳥関連過敏性肺炎の1例.アレルギー 67(7):954-8, 2018
  10. 寺田友子、貫井義久、瀬間学、日下祐、岡本師、稲瀬直彦.クッシング症候群に合併し肺クリプトコッカス症と臨床診断された1例.日本呼吸器学会誌 2018;7(1):44-48.
  11. 倉重理絵、立石知也、土屋公威、稲瀬直彦.進行肺癌に合併した気管支食道瘻を伴う重症肺炎を救命しえた1例.気管支学 2018;40(2):117-120.

著書

  1. 宮崎 泰成 呼吸器疾患 診断治療アプローチ 間質性肺炎・肺線維症と類縁疾患 慢性過敏性肺炎 中山書店 2018:240-248.
  2. 宮崎 泰成 秀島雅之 編 いびき!?眠気!?睡眠時無呼吸症を疑ったら  羊土社 2018
  3. 坂下 博之 脊髄圧迫 新臨床腫瘍学 改訂第5版 南江堂 695-697

総説

  1. 宮崎泰成 他 アレルギー・免疫 過敏性肺炎の基礎と臨床アップデート 医薬ジャーナル社 vol 25 No 12 2018
  2. 井上幸久 宮崎泰成 稲瀬直彦 【薬物アレルギーをめぐって】 薬物・化学物質による過敏性肺炎 アレルギー・免疫 2018:25;676-683.
  3. 増尾昌宏 宮崎泰成 稲瀬直彦 【症例から考える難治性びまん性肺疾患-病態と最新治療戦略】特発性間質性肺炎 特発性肺線維症 慢性安定期 特発性肺線維症をどう考えるか 呼吸器ジャーナル 2018:66;214-223.
  4. 惠島将 増尾昌宏 宮崎泰成 特集 リウマチ性の肺病変 関節リウマチの間質性肺炎 リウマチ科 2018:60;10-19.
  5. 宮崎泰成 気管支鏡セミナーより 検体採取の基礎(TBB/TBLB BAL):末梢病変検体採取法 気管支学 2018:40;386-389
  6. 白井剛 宮崎泰成 【日本人が見つけた自己抗原・抗原】 過敏性肺炎の原因抗原 夏型過敏性肺炎の原因抗原特定に至るまでの経緯と鳥関連過敏性肺炎の抗原同定の試み 呼吸臨床2018:2;1-12.
  7. 立石 知也. 【もっとうまくいく! 病診連携の「伝え方」-わかりやすく伝えるための診療情報提供書作成のコツ】(第II章)<診療科別>コンサルトのポイント D.呼吸器科へコンサルト 間質性肺炎(精査・治療) 内科 2018:122(3);547-549

2017年業績

原著

  1. Shirai T, Furusawa H, Furukawa A, Ishige Y, Uchida K, Miyazaki Y, Eishi Y, Inase N. Protein antigen of bird-related hypersensitivity pneumonitis in pigeon serum and dropping. Respir Res. 2017 Apr 20;18(1):65.
  2. Uchibori K, Inase N, Araki M, Kamada M, Sato S, Okuno Y, Fujita N, Katayama R. Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer. Nat Commun. 2017 Mar 13;8:14768
  3. Sakakibara R, Inamura K, Tambo Y, Ninomiya H, Kitazono S, Yanagitani N, Horiike A, Ohyanagi F, Matsuura Y, Nakao M, Mun M, Okumura S, Inase N, Nishio M, Motoi N, Ishikawa Y. EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer. Clin Lung Cancer. 2017 Sep;18(5):527-534.e1.
  4. Adachi Y, Watanabe K, Kita K, Kitai H, Kotani H, Sato Y, Inase N, Yano S, Ebi H. Resistance mediated by alternative receptor tyrosine kinases in FGFR1-amplified lung cancer. Carcinogensis. 2017 Oct 26;38(11):1063-1072.
  5. Sakakibara Y, Suzuki Y, Fujie T, Akashi T, Iida T, Miyazaki Y, Eishi Y, Inase N. Radiopathological features and identification of Mycobacterial infections in granulomatous nodules resected from the lung. Respiration. 2017;93(4):264-270.
  6. Ochi J, Ohtani Y, Takemura T, Akashi T, Tateishi T, Miyazaki Y, Inase N, Yoshizawa Y. Histological variability and consequences in chronic bird-related hypersensitivity pneumonitis. Respirology. 2017;22:1350-1356
  7. Chiba S, Okayasu K, Tsuchiya K, Tamaoka M, Miyazaki Y, Inase N, Sumi Y. The C-jun N-terminal kinase signaling pathway regulates cyclin D1 and cell cycle progression in airway smooth muscle cell proliferation. Int J Clin Exp Med 2017;10:2252-2262
  8. 八木 太門、小林 寛明、今瀬 玲菜、山本 一樹、三島 有華、尾形 朋之、山下 高明、土屋 公威、稲瀬 直彦:慢性閉塞性肺疾患患者における低頻度・短時間の外来呼吸リハビリテーションの有効. 日本呼吸ケア・リハビリテーション学会誌 27: 1881-7319, 2017.

総説

  1. 宮崎泰成 古澤春彦 間質性肺炎・肺線維症—難解な疾患が見えてくるー 治療/実地医家が知っておくべき治療のポイント ステロイド、免疫抑制薬の取り扱い Medical Practice 2017;34:633-637.
  2. 宮崎泰成 稲瀬直彦 医学と医療の最前線 過敏性肺炎の病態と治療の最前線. 日本内科学会雑誌. 2017; 106: 1212-1220.
  3. 宮崎泰成 稲瀬直彦 特集 呼吸器系指定難病 特発性間質性肺炎(指定難病85)呼吸器内科 科学評論社 2017;32:430-436.
  4. 宮崎泰成 特集「免疫学の新展開と呼吸器疾患」 過敏性肺炎とマクロファージ THE LUNG perspectives 2017;4:391-395.
  5. 井上 幸久 稲瀬 直彦【仕事と病気】職業性の過敏性肺炎 成人病と生活習慣病 2017; 47: 969-974.
  6. 瀬間 学 稲瀬 直彦 夏型過敏性肺炎の診断と治療 新薬と臨牀2017; 66: 803-807.
  7. 土屋 公威 稲瀬 直彦 間質性肺炎・肺線維症の診療に必要な具体的知識とその活用 類縁疾患の診断・管理 慢性過敏性肺炎・粉塵曝露肺 Medical Practice 2017; 34: 605-611.
  8. 立石 知也 稲瀬 直彦 間質性肺疾患,またはびまん性肺疾患 過敏性肺炎の画像所見の特徴は? 呼吸器ジャーナル 2017; 65: 108-113.
  9. 石塚 聖洋 稲瀬 直彦 過敏性肺炎の吸入誘発試験の実際 呼吸器内科 2017; 3: 1884-2887.

2016年業績

原著

  1. Suhara K, Miyazaki Y, Okamoto T, Ishizuka M, Tsichiya K, Inase N:Fragmented gelsolins are increased in rheumatoid arthritis-associated interstitial lung disease with usual interstitial pneumonia pattern. Allergol Int. 65: 88-95, 2016.
  2. 貫井義久、岡本師、柴田翔、瀬間学、日下祐、榊原里江、榊原ゆみ、藤江俊秀、稲瀬直彦: 間質性肺炎に合併した続発性肺 クリプトコッカス症の臨床的検討.日胸75:319-325, 2016.
  3. 八木太門、小林寛明、今瀬玲菜、三島有華、尾形朋之、山下高明、土屋公威、稲瀬直彦:フッ素樹脂加工鍋の過燃焼にて発症したポリマーヒュームによる肺障害の1例.気管支学38: 190-194, 2016.
  4. Chiba S, Tsuchiya K, Akashi T, Ishizuka M, Okamoto T, Furusawa H, Tateishi T, Kishino M, Miyazaki Y, Tateishi U, Takemura T, Inase N: Chronic hypersensitivity pneumonitis with a usual interstitial pneumonia (UIP)-like pattern: Correlation between histopathological and clinical findings.. Chest 149: 1473-1481, 2016.
  5. 倉重理絵、坂下博之、東盛志、内堀健、木原淳、稲瀬直彦:アレクチニブ中止後に急速に増悪し、クリゾチニブが著効したALK陽性肺腺癌の1剖.肺癌56:308-313, 2016.
  6. 高野聡子、馬嶋秀考、原哲、貫井義久、川上直樹、島田裕之、井上幸久、山内秀太、中川淳、小林亜紀子、山崎啓一、神靖人、稲瀬直彦:縦隔癌に対する化学放射線治療後に発症した放射線誘発肺癌の1例.気管支学38: 365-370, 2016.
  7. 榛沢理、藤江俊秀、高野聡子、稲瀬直彦:EBウイルス関連T細胞リンパ増殖症による肺病変を呈した1例.気管支学38: 405-409, 2016.
  8. 貫井義久、岡本師、寺田友子、榊原里江、柴田翔、瀬間学、千葉佐保子、玉岡明洋、稲瀬直彦:透視下でのエアリーク確認が責任気管支同定の一助となりEWS充塡が奏効した難治性気胸の1例.日胸75: 1172-1177, 2016
  9. 榛沢理、立石知也、小林正嗣、大久保憲一、伊藤崇、稲瀬直彦:傍腫瘍性ネフローゼ症候群を合併し化学療法に続き手術を施行しえた悪性胸膜中皮腫の1例.肺癌56: 342-348,2016
  10. Sakakibara Y, Ohtani Y, Jinta T, Fujie T, Miyazaki Y, Inase N, Saito R, Akaza M, Sasano T, Sumi Y: Concentration of immunoglobulin G antibodies against pertussis toxin does not decrease over a long period of time in Japan. Intern Med 55: 3257-3263, 2016
  11. Masuo M, Miyazaki Y, Suhara K, Ishizuka M, Fujie T, Inase N: Factors associated with positive inhalation provocation test results in subjects suspected of having chronic bird-related hypersensitivity pneumonitis. Respir Investig 54: 454-461, 2016

総説

  1. 宮崎泰成、稲瀬直彦:過敏性肺炎. 内科117(2):259-262, 2016.2
  2. 土屋公威、稲瀬直彦:NSAIDによる肺障害(好酸球性肺炎など)とその対処法. リウマチ科55:53-58,2016.4
  3. 稲瀬直彦:過敏性肺炎:診断と治療の進歩. 呼吸器内科29(4):289-294, 2016.4
  4. 宮崎泰成:過敏性肺炎の慢性化機序. 呼吸器内科29(4):324-329, 2016.4
  5. 稲瀬直彦:過敏性肺炎の最近の動向. 日本内科学会雑誌105・991-996・2016
  6. 稲瀬直彦:過敏性肺炎Update. 最新医学71・1321-1327・2016
  7. 稲瀬直彦:せきの鑑別診断と検査法. JOHNS 32・937-940・2016
  8. 稲瀬直彦:過敏性肺炎とIPFの異同と管理. 呼吸器内科30・165-170・2016
  9. 玉岡明洋、稲瀬直彦:健診・検診・人間ドック 読み方・進め方ガイドブック 胸部X線. 内科 118・590-594・2016
  10. Y, Tsutsui T, Inase N:Treatment and monitoring of hypersensitivity pneumonitis. Expert Rev Clin Immunol. 2016 Sep;12(9):953-62.

2015年業績

原著

  1. Okamoto T, Tsutsui T, Suhara K, Furusawa H, Miyazaki Y, Inase N: Seasonal variation of serum KL-6 and SP-D levels in birdrelated hypersensitivity pneumonitis. Sarcoidosis Vasculitis and Diffuse Lung Diseases 31:364-367, 2015
  2. Chiba S, Uchibori K, Fujiwara T, Ogata T, Yamauchi S, Shirai T, Masuo M, Okamoto T, Tateishi T, Furusawa H, Fujie T, Sakashita H, Tsuchiya K, Tamaoka M, Miyazaki Y, Inase N, Sumi Y: Dielectric blood coagulometry as a novel coagulation test. Journal of scientific research & reports 4(3): 180-188, 2015
  3. Suhara K, Miyazaki Y, Okamoto T, Yasui M, Tsuchiya K, Inase N:Utility of immunological tests for bird-related hypersensitivity pneumonitis. Respiratory Investigation 53:13-21, 2015
  4. Yamazaki H, Sakai R, Koike R, Miyazaki Y, Tanaka M, Nanki T, Watanabe K, Yasuda S, Kurita T, Kaneko Y, Tanaka Y, Nishioka Y, Takasaki Y, Nagasaka K, Nagasawa H, Tohma S, Dohi M, Sugihara T, Sugiyama H, Kawaguchi Y, Inase N, Ochi S, Hagiyama H, Kohsaka H, Miyasaka N, Harigai M: Assessment of risks of pulmonary infection during 12 months following immunosuppressive treatment for active connective tissue diseases: a large-scale prospective cohort study. The journal of rheumatology 42(4):614-622, 2015
  5. Sugiura M, Mitaka C, Haraguchi G, Tomita M, Inase N: Polymyxin b-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock. Journal of intensive care 3:14, 2015
  6. Ishizuka M, Miyazaki Y, Tateishi T, Tsutsui T, Tsuchiya K, Inase N: Validation of inhaled provocation test in chronic bird-related hypersensitivity pneumonitis and new prediction score. Ann Am Thorac Soc 12: 167-173, 2015
  7. 瀬間学、岡本師、土屋公威、日下拓、貫井義久、酒井友子、榊原里江、柴田翔、稲瀬直彦:EBUS-TBNAで診断できなかった縦隔リンパ節結核の1例 気管支学37(3):319-323, 2015
  8. 三島有華、今瀬玲菜、八木太門、尾形朋之、土屋公威、稲瀬直彦:多発結節影と間質性陰影が2ヶ月で自然寛解した血管免疫芽球性T細胞リンパ腫の1例. 日呼吸誌4:240-243, 2015
  9. Yorozu P, Furukawa A, Uchida K, Akashi T, Kakegawa T, Ogawa T, Minami J, Suzuki Y, Awano N, Furusawa H, Miyazaki Y, Inase N, Eishi Y: Propionibacterium acnes catalase induces increased Th1 immune response in sarcoidosis patients. Respir Investig 53: 161-169, 2015
  10. Tanaka M, Koike R, Sakai R, Saito K, Hirata S, Nagasawa H, Kameda H, Hara M, Kawaguchi Y, Tohma S, Takasaki Y, Dohi M, Nishioka Y, Yasuda S, Miyazaki Y, Kaneko Y, Nanki T, Watanabe K, Yamazaki H, Miyasaka N, Harigai M: Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumonia. Mod Rheumatol Jul;25(4):609-614, 2015
  11. Ishizuka M, Miyazaki Y, Masuo M, Suhara K, Tateishi T, Yasui M, Inase N: Interleukin-17A and neutrophils in a murine model of bird-related hypersensitivity pneumonitis. PLoS ONE doi:10.1371/journal.pone.0137978, 2015.
  12. 井上幸久、榛沢理、矢澤克昭、高崎寛司、磯貝進、稲瀬直彦:間質性肺炎急性増悪により顕在化した肝肺症候群の1例.日呼吸誌4:389-393, 2015
  13. Tsutsui T, Miyazaki Y, Kuramochi J, Uchida K, Eishi Y, Inase N: The amount of avian antigen in chronic bird-related hypersensitivity pneumonitis. Ann Am Thorac Soc 12: 1013-1021, 2015.
  14. Miyazaki Y, Azuma A, Inase N, Taniguchi H, Ogura T, Inoue E, Takeuchi M, Yoshizawa Y, Sugiyama Y, Kudoh S, the IPF trial group in Japan: Cyclosporin A combined with low-dose corticosteroid treatment in patients with idiopathic pulmonary fibrosis. Respir Investig 53: 288-295, 2015.
  15. Okamoto T, Fujii M, Furusawa H, Tsuchiya K, Miyazaki Y, Inase N: Usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis. Respir Med 109: 1576-1581, 2015.
  16. Tsutsui T, Miyazaki Y, Okamoto T, Tateishi T, Furusawa H, Tsuchiya K, Fujie T, Tamaoka M, Sakashita H, Sumi Y, Inase N: Antigen avoidance tests for diagnosis of chronic hypersensitivity pneumonitis.Respir Investig 53: 217-224, 2015

総説

  1. 宮崎泰成、稲瀬直彦:慢性過敏性肺炎と特発性間質性肺炎 呼吸器内科27(2):118-124, 2015.2
  2. 稲瀬直彦:View Spot 医学教育分野別認証評価を受審して 内科115(5):722, 2015.5
  3. 土屋公威、稲瀬直彦:肺の浮腫・うっ血の病態と治療法. Fluid Management Renaissance 5(2):143-148, 2015.4
  4. 稲瀬直彦:過敏性肺炎と特発性肺線維症の関係とは? Modern Physician 35(6):779-782, 2015.6
  5. 須原宏造、宮崎泰成:薬剤性肺障害と特発性肺線維症の関係とは?Modern Physician 35(6):791-794, 2015.6
  6. 杉山幸比古、山口哲生、稲瀬直彦:座談会 慢性咳嗽について. Current Therapy 33(6):624-631, 2015.6
  7. 立石知也、稲瀬直彦:内科疾患の診断基準・病型分類・重症度 過敏性肺炎. 内科115(6):919-921, 2015.6
  8. 古澤春彦、稲瀬直彦:内科疾患の診断基準・病型分類・重症度 サルコイドーシス. 内科115(6):1177-1179, 2015.6
  9. 稲瀬直彦:慢性咳嗽の診断と対応 成人病と生活習慣病45(6):691-696,  2015.6
  10. 杉浦真貴子、古澤春彦、稲瀬直彦:IPFに併発する難治性気胸の管理. 呼吸器内科 28(5):365-369, 2015.11
  11. 宮崎泰成、稲瀬直彦:大気汚染と間質性肺炎. THE LUNG perspectives 23(4):368-372, 2015.11

2014年業績

原著

  1. Ono H, Motoi N, Nagano H, Miyauchi E, Ushijima M, Matsuura M, Okumura S, Nishio M, Hirose T, Inase N, Ishikawa Y. Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer. Cancer Med. 2014; 3: 632-642.
  2. Komazaki Y, Miyazaki Y, Fujie T, Sakashita H, Tsuchiya K, Tamaoka M, Sumi Y, Maruyama Y, Nanki T, Inase N. Serodiagnosis of Mycobacterium avium complex pulmonary disease in rheumatoid arthritis. Respiration. 2014; 87: 129-135.
  3. Iijima Y, Furusawa H, Tateishi T, Tsuchiya K, Fujie T, Tamaoka M, Sakashita H, Miyazaki Y, Sumi Y, Hosono Y, Nakashima R, Mimori T, Inase N. Amyopathic dermatomyositis complicated with eosinophilic pneumonia. Intern Med. 2014; 53: 1539-1544.
  4. Furusawa H, Miyazaki Y, Sonoda S, Tsuchiya K, Yaguchi T, Kamei K, Inase N. Penicilliosis marneffei complicated with interstitial pneumonia. Intern Med. 2014;53:321-323.
  5. Sakakibara Y, Kishimoto K, Kojima K, Fujie T, Inase N. Fatal nontuberculous mycobacterial lung disease caused by Mycobacterium kyorinense: a case report with five years of follow-up. Kekkaku. 2014; 89: 509-513.
  6. 柴田 翔、土屋 公威、岡本 師、日下 祐、瀬間 学、貫井 義久、酒井 友子、榊原 里江、稲瀬 直彦. 外科的気管生検にて診断した気管気管支骨軟骨形成症の1例. 気管支学 2014; 36: 374-378.
  7. 山下 理奈子、玉岡 明洋、瀧 玲子、宮崎 泰成、稲瀬 直彦、明石 巧. 心膜原発悪性中皮腫の1剖検例. 肺癌 2014; 54: 158-164.
  8. 尾形 朋之、土屋 公威、石塚 聖洋、岡本 師、白井 剛、増尾 昌宏、筒井 俊晴、坂下 博之、宮崎 泰成、稲瀬 直彦. 気腫を伴う慢性過敏性肺炎の臨床的検討. 日本呼吸器学会誌 2014; 3: 214-220.

総説

  1. 土屋 公威、稲瀬 直彦. 【びまん性肺疾患の併存症を考える】 過敏性肺炎と併存症. 呼吸器内科 2014; 26: 196-201.
  2. 稲瀬 直彦. 過敏性肺炎の診断と治療. 日本内科学会雑誌2014; 103: 2269-2274.
  3. 稲瀬 直彦. 【かかりつけ医のための間質性肺炎診療の手引き】 鑑別が難しい類縁疾患 慢性過敏性肺炎. 日本医師会雑誌 2014; 143: 991-994.
  4. 宮崎 泰成、稲瀬 直彦. 【大気汚染と呼吸器疾患】 大気汚染と特発性間質性肺炎. 呼吸器内科 2014; 25: 502-508.

2013年業績

原著

  1. Nei Y, Obata-Ninomiya K, Tsutsui H, Ishiwata K, Miyasaka M, Matsumoto K, Nakae S, Kanuka H, Inase N, Karasuyama H. GATA-1 regulates the generation and function of basophils. Proc Natl Acad Sci U S A. 2013; 110: 18620-18625.
  2. Okamoto T, Miyazaki Y, Ogura T, Chida K, Kohno N, Kohno S, Taniguchi H, Akagawa S, Mochizuki Y, Yamauchi K, Takahashi H, Johkoh T, Homma S, Kishi K, Ikushima S, Konno S, Mishima M, Ohta K, Nishioka Y, Yoshimura N, Munakata M, Watanabe K, Miyashita Y, Inase N. A nationwide epidemiological survey of chronic hypersensitivity pneumonitis in Japan. Respir Investig. 2013; 51: 191-199.
  3. Komazaki Y, Sakashita H, Furuiye M, Fujie T, Tamaoka M, Sumi Y, Miyazaki Y, Kojima K, Jin Y, Inase N. Feasibility study of adjuvant chemotherapy of S-1 and carboplatin for completely resected non-small cell lung cancer. Chemotherapy. 2013; 59: 35-41.
  4. Sakashita H, Inoue H, Akamine S, Ishida T, Inase N, Shirao K, Mori M, Mimori K. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer. Ann Surg Oncol. 2013; 20 Suppl 3: S590-598.
  5. Miyazaki Y, Unoura K, Tateishi T, Akashi T, Takemura T, Tomita M, Inase N, Yoshizawa Y. Higher serum CCL17 may be a promising predictor of acute exacerbations in chronic hypersensitivity pneumonitis. Respir Res. 2013; 14: 57. [Epub ahead of print]
  6. Chiba S, Tsuchiya K, Sakashita H, Ito E, Inase N. Rifampicin-induced acute kidney injury during the initial treatment for pulmonary tuberculosis: a case report and literature review. Intern Med. 2013; 52: 2457-2460.
  7. 石渡 庸夫、谷口 優子、稲瀬 直彦.プロピルチオウラシルの投与と関連した好酸球性胸水の1例.日本呼吸器学会誌 2013; 2: 437-441.
  8. 岸 雅人、佐内 文、尾熊 洋子、石月 亜由美、石田 英恵、石井 俊夫、寺田 千代美、小松 友子、杉山 清子、稲瀬 直彦.当院の呼吸リハビリテーションの取り組み 包括的支援チームの結成と専門外来の開設.日本呼吸ケア・リハビリテーション学会誌 2013; 23: 204-209.
  9. 古澤 春彦、宮崎 泰成、土屋 公威、稲瀬 直彦.過敏性肺炎と肺サルコイドーシスの合併が疑われた3例.日本サルコイドーシス/肉芽腫性疾患学会雑誌 2013; 33: 127-132.
  10. 駒崎 義利、宮崎 泰成、石塚 聖洋、筒井 俊晴、須原 宏造、稲瀬 直彦.関節リウマチに合併した肺Mycobacterium avium intracellulare complex症における抗Glycopeptidolipid抗体の検討.Therapeutic Research2013; 34: 755-756.
  11. 駒崎 義利、角 勇樹、筒井 俊晴、石塚 聖洋、岡本 師、藤江 俊秀、土屋 公威、玉岡 明洋、坂下 博之、宮崎 泰成、稲瀬 直彦.器質化肺炎を呈したIgG4関連肺疾患の1例.日本胸部臨床 2013; 72: 306-311.
  12. 内堀 健、須原 宏造、千葉 佐保子、土屋 公威、藤江 俊秀、玉岡 明洋、坂下 博之、稲瀬 直彦.気管支食道瘻に対して食道バイパス術を行った肺扁平上皮癌の1例.気管支学 2013; 35: 150-155.
  13. 島田 裕之、須原 宏造、岡本 師、古澤 春彦、立石 知也、土屋 公威、藤江 俊秀、玉岡 明洋、坂下 博之、角 勇樹、宮崎 泰成、稲瀬 直彦.EBUS-TBNAにて診断した縦隔原発大細胞型B細胞性リンパ腫の1例.気管支学 2013; 35: 650-655.
  14. 佐内 文、大河内 康実、笠井 昭吾、徳田 均、宮崎 泰成、稲瀬 直彦.ウロキナーゼ胸腔内注入療法が有用であった膿胸、肺炎随伴性胸水の9例.お茶の水医学雑誌 2013; 61: 277-283.
  15. 井上 幸久、貫井 義久、島田 裕之、川上 直樹、神 靖人、吉村 信行、稲瀬 直彦.人工妊娠中絶術後に発症し肺胞出血を呈した羊水塞栓症の1例.気管支学 2013; 35: 418-423.

総説

  1. 玉岡 明洋,稲瀬 直彦.【胸膜・胸壁疾患の診断と治療の進歩】 石綿関連良性胸膜疾患(胸膜プラーク、びまん性胸膜肥厚、良性石綿胸水).呼吸器内科 2013; 24: 431-437.
  2. 稲瀬 直彦.【過敏性肺炎:最近のトピックス】 難治性疾患としての慢性過敏性肺炎.細胞 2013; 45: 552-554.
  3. 古澤 春彦、稲瀬 直彦.【サルコイドーシスのすべて】 サルコイドーシスの鑑別すべき疾患・病態.成人病と生活習慣病2013; 43: 1271-1275.
  4. 宮崎 泰成、稲瀬 直彦.【肺線維症治療薬の現況】 ステロイド、免疫抑制薬併用療法の評価.日本胸部臨床 2013; 72: 1060-1069.
  5. 立石 知也、稲瀬 直彦.【2次性間質性肺炎の画像診断をめぐって】 慢性過敏性肺炎.日本胸部臨床 2013; 72: 960-966.
  6. 土屋 公威、稲瀬 直彦.歯科技工士塵肺.呼吸器内科 2013; 23: 506-510.

著書

  1. 藤江 俊秀、稲瀬 直彦.【これだけは知っておきたい酸塩基平衡】 呼吸性アシドーシスの診断と治療.月刊レジデント 2013; 6: 70-75.

2012年業績

原著

  1. Okamoto T, Miyazaki Y, Shirahama R, Tamaoka M, Inase N. Proteome analysis of bronchoalveolar lavage fluid in chronic hypersensitivity pneumonitis. Allergol Int 2012; 61: 83-92.
  2. Furusawa H, Suzuki Y, Miyazaki Y, Inase N, Eishi Y. Th1 and Th17 immune responses to viable propionibacterium acnes in patients with sarcoidosis. Respiratory investigation 2012; 50: 104-109.
  3. Tsuchiya K, Siddiqui S, Risse PA, Hirota N, Martin JG. The presence of LPS in OVA inhalations affects airway inflammation and AHR but not remodeling in a rodent model of asthma. Am J Physiol Lung Cell Mol Physiol 2012; 303: L54-63.
  4. Chiba S, Jinta T, Chohnabayashi N, Fujie T, Sumi Y, Inase N. Bronchiolitis obliterans organising pneumonia syndrome presenting with neutrophilia in bronchoalveolar lavage fluid after breast-conserving therapy. BMJ Case Rep 2012 Mar 20; pii: bcr0920114857. doi:10.1136/bcr.09.2011.4857.
  5. Honda T, Kobayashi H, Saiki M, Sogami Y, Miyashita Y, Inase N. Gastroesphageal variceal hemorrhage induced by metastatic liver tumor of lung cancer. Case Rep Oncol 2012; 5: 644-650.
  6. 高山幸二、倉持仁、稲瀬直彦. 環境調査と誘発試験が有用であった夏型過敏性肺炎の1例. 日呼吸会誌 2012; 1: 119-123.
  7. 尾形朋之、土屋公威、園田史朗、山内秀太、石塚聖洋、根井雄一郎、藤江俊秀、稲瀬直彦. びまん性肺胞傷害を認めたテムシロリムスによる薬剤性肺障害の1例. 気管支学 2012; 34: 568-572.
  8. 山内秀太、玉岡明洋、岡本師、尾形朋之、土屋公威、坂下博之、宮崎泰成、稲瀬直彦:超音波気管支鏡下針生検(EBUS-TBNA)で診断した上縦隔発生神経鞘腫の1例. 気管支学 2012; 34: 616-620.
  9. 石塚聖洋、宮崎泰成、岡本師、駒崎義利、玉岡明洋、瀬山邦明、稲瀬直彦. 気胸の家族歴と特徴的なCT所見を認めたBirr-Hogg-Dube症候群の1例. お茶の水醫學雑誌 2012; 60: 113-117.

総説

  1. 宮崎泰成、岸雅人、見高恵子、安井牧人、仁多寅彦、稲瀬直彦. 過敏性肺炎の病態と治療. 呼吸 2012; 31: 101-115.
  2. 稲瀬直彦. 間質性肺炎に潜む鳥飼病について. 呼吸 2012; 31: 453-457.
  3. 宮崎泰成、稲瀬直彦:びまん性肺疾患の慢性期の治療. 総合臨床2011; 60: 2425-2433.

著書

  1. 宮崎泰成. 細菌性肺炎 膠原病の肺合併症診断マニュアル 宮坂信之 / 編 2012: 124-136 医薬ジャーナル社 東京
  2. 稲瀬直彦. 薬物治療(治療と薬理メカニズム):免疫抑制剤 間質性肺炎を究める 滝澤始 / 編 2012: 159-162メディカルレビュー社 東京

2011年業績

原著

  1. Mitaka K, Miyazaki Y, Yasui M, Furie M, Miyake S, Inase N, Yoshizawa Y. Th2-baised immune responses are important in a murine model of chronic hypersensitivity pneumonitis. Int Arch Aller Immun 2011; 154: 264-274.
  2. Unoura K, Miyazaki Y, Sumi Y, Tamaoka M, Sugita T, Inase N. Identification of fungal DNA in BALF from patients with home-related hypersensitivity pneumonitis. Respir Med 2011; 105: 1696-1703.
  3. Takayama K, Kuramochi J, Oinuma T, Kaneko H, Kurasawa S, Yasui M, Okayasu K, Ono H, Inase N. Clinical features of the 2009 swine-origin influenza A (H1N1) outbreak in Japan. J Infect Chemother 2011; 17: 401-406.
  4. Tateishi T, Ohtani Y, Takemura T, Akashi T, Miyazaki Y, Inase N, Yoshizawa Y. Serial high-resolution computed tomography findings of acute and chronic hypersensitivity pneumonitis induced by avian antigen. J Comput Assist Tomogr 2011; 35: 272-279.
  5. Takayama S, Tamaoka M, Takayama K, Okayasu K, Tsuchiya K, Miyazaki Y, Sumi Y, Martin JG, Inase N. Synthetic double-stranded RNA enhances airway inflammation and remodeling in a rat model of asthma. Immunology 2011; 134: 140-150.
  6. Okamoto T, Miyazaki Y, Sakakibara Y, Tamaoka M. Sumi Y, Inase N. Successful diagnosis of a combined thymic epithelial tumor by endobronchial ultrasound-guided transbronchial needle aspiration. J Med Dent Sci 2011; 58: 123-126.
  7. Kuramochi J, Inase N, Miyazaki Y, Kawachi H, Takemura T, Yoshizawa Y. Lung cancer in chronic hypersensitivity pneumonitis. Respiration 2011; 82: 263-267.
  8. Fujii M, Sumi Y, Atarashi K, Takemura T, Inase N : Muscle weakness in extremities and diffuse centrilobular nodules in lungs. Thorax 2011; 66: 564-547.

総説

  1. 稲瀬直彦:慢性過敏性肺炎と特発性間質性肺炎. 最新医学 2011; 66: 98-103.
  2. 稲瀬直彦:座談会/過敏性肺炎の診断と治療update. 呼吸 2011; 30: 593-602.
  3. 宮崎泰成、稲瀬直彦:びまん性肺疾患の慢性期の治療. 総合臨床2011; 60: 2425-2433.
  4. 土屋公威、稲瀬直彦:抗微生物薬による肺障害. 呼吸器内科2011; 20: 143-148.
  5. 土屋公威、稲瀬直彦:薬剤性肺障害をいかにみつけ診断するか. 成人病と生活習慣病 2011; 41: 855-860.
  6. 土屋公威、稲瀬直彦:自己免疫疾患の周辺疾患と肺病変 過敏性肺炎. 呼吸器内科2011; 20: 422-429.

著書

  1. 稲瀬直彦:鑑別診断 日本呼吸器学会びまん性肺疾患 診断・治療ガイドライン作成委員会 / 編 特発性間質性肺炎診断と治療の手引き 2011: 22-23. 南江堂 東京
  2. 稲瀬直彦、吉澤靖之:過敏性肺炎 2011-2012 EMB 呼吸器疾患の治療 永井厚志、大田健、江口研二、橋本修 / 編 2011: 159-169. 中外医学社 東京